Impella Program. Protocols & Tools. Recovering hearts. Saving lives.

Size: px
Start display at page:

Download "Impella Program. Protocols & Tools. Recovering hearts. Saving lives."

Transcription

1 Impella Program Protocols & Tools Recovering hearts. Saving lives.

2 Recovering hearts. Saving lives.

3 Product Approval Information PROTECTED PCI INDICATION FOR USE The Impella 2.5 and Impella CP Systems are temporary ( 6 hours) ventricular support devices indicated for use during high-risk percutaneous coronaryinterventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 and Impella CP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events. The Impella 2.5 and Impella CP Systems are indicated for short term use ( 4 days) for the treatment of ongoing cardiogenic shock that occurs immediately (< 48 hours) following acute myocardial infarction or open heart surgery as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures (including volume loading and use of pressors and inotropes, with or without IABP). The intent of treatment with Impella 2.5 and Impella CP is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function. CONTRAINDICATIONS The Impella 2.5 and Impella CP are contraindicated for use with patients experiencing any of the following conditions: Mural thrombus in the left ventricle; Presence of a mechanical aortic valve or heart constrictive device; Aortic valve stenosis/calcification (equivalent to an orifice area of 0.6 cm2 or less); Moderate to severe aortic insufficiency (echocardiographic assessment graded as +2); Severe peripheral arterial disease precluding placement of the Impella 2.5 and Impella CP Systems; Significant right heart failure*; Combined cardiorespiratory failure*; Presence of an Atrial or Ventricular Sepal Defect (including post-infarct VSD)*; Left ventricular rupture*; Cardiac tamponade* * This condition is a contraindication for the cardiogenic shock indication only. POTENTIAL ADVERSE EVENTS Acute renal dysfunction, Aortic valve injury, Bleeding, Cardiogenic shock, Cerebral vascular accident/stroke, Death, Hemolysis, Limb ischemia, Myocardial infarction, Renal failure, Thrombocytopenia and Vascular injury In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with the Impella 2.5. Visit: to learn more. CARDIOGENIC SHOCK INDICATION FOR USE The Impella 2.5, Impella CP, Impella 5.0 and Impella LD catheters, in conjunction with the Automated Impella Controller, are temporary ventricular support devices intended for short term use ( 4 days for the Impella 2.5 and Impella CP, and 6 days for the Impella 5.0 and LD) and indicated for the treatment of ongoing cardiogenic shock that occurs immediately (< 48 hours) following acute myocardial infarction or open heart surgery as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures.* The intent of the Impella system therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function. * Optimal medical management and convention treatment measures include volume loading and use of pressors and inotropes, with or without IABP. CONTRAINDICATIONS The Impella devices are contraindicated for use in this indication for patients experiencing the following conditions: Mural thrombus in the left ventricle; Presence of a mechanical aortic valve or heart constrictive device; Aortic valve stenosis/calcification (equivalent to an orifice area of 0.6 cm2 or less (with respect to the Impella 2.5)) or (graded as +2 equivalent to an orifice area of 1.5 cm2 or less (with respect to the Impella CP, Impella 5.0 and Impella LD)); Moderate to severe aortic insufficiency (echocardiographic assessment graded as +2); Severe peripheral arterial disease precluding placement of the Impella System; Significant right heart failure; Combined cardiorespiratory failure; Ongoing CPR; Presence of an Atrial or Ventricular Septal Defect (including postinfarct VSD); Left ventricular rupture; and Cardiac tamponade. POTENTIAL ADVERSE EVENTS Acute renal dysfunction, Aortic valve injury, Bleeding, Cerebral vascular accident/stroke, Death, Hemolysis, Limb ischemia, Renal failure, Thrombocytopenia and Vascular injury The institution of circulatory support using Impella has not been studied in the following conditions: presence of irreversible end-organ failure; and presence of severe anoxic brain injury In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with the use of Impella in this indication. Visit: to learn more. RIGHT-SIDE SUPPORT INDICATION FOR USE The Impella RP System is indicated for providing circulatory assistance for up to 14 days in pediatric or adult patients with a body surface area 1.5 m2 who develop acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or open-heart surgery. CONTRAINDICATIONS The Impella RP is contraindicated for use with patients experiencing any of the following conditions: (1) Disorders of the pulmonary artery wall that would preclude placement or correct positioning of the Impella RP device; (2) Mechanical valves, severe valvular stenosis or valvular regurgitation of the tricuspid valve or pulmonary valve; (3) Mural thrombus of the right atrium or vena cava; (4) Anatomic conditions precluding insertion of the pump; (5) Other illnesses or therapy requirements precluding use of the pump; and (6) Presence of a vena cava filter or caval interruption device, unless there is clear access from the femoral vein to the right atrium that is large enough to accommodate a 22 Fr catheter. POTENTIAL ADVERSE EVENTS Additionally, potential for the following risks has been found to exist with the use of the Impella RP: Arrhythmia; Atrial fibrillation; Bleeding; Cardiac tamponade; Cardiogenic shock; Death; Device Malfunction; Hemolysis; Hepatic failure; Insertion site infection; Perforation; Phlegmasia cerulea dolens (a severe form of deep venous thrombosis); Pulmonary valve insufficiency; Respiratory dysfunction; Sepsis; Thrombocytopenia; Thrombotic vascular (non-central nervous system) complication; Tricuspid valve injury; Vascular injury; Venous thrombosis; Ventricular fibrillation and/or tachycardia The Impella RP is approved for use as a Humanitarian Device. It s effectiveness for the above indication has not been demonstrated.

4 Contents Summary i Introduction iii Protected PCI with Impella 2.5 iv Improving Outcomes in Cardiogenic Shock v Clinical Guidelines for Impella vi Impella Heart Pump Clinical Protocols 2 Sample Protected PCI with Impella 2.5 Device Clinical Decision Tree 3 Sample AMI Cardiogenic Shock Algorithm 3-9 Impella 2.5 /Impella CP Catheter Set-Up Procedures 10 Impella 5.0 /Impella LD Catheter Set-Up Procedures 13 Impella 2.5 /Impella CP Catheter Insertion Procedures 16 Impella 5.0 Catheter Insertion Procedure 22 Impella LD Catheter Insertion Procedure 28 Impella 2.5 /Impella CP Purge System Management Procedures 31 Impella 5.0 /Impella LD Purge System Management Procedures 35 Transferring Impella 2.5 /Impella CP Supported Patient 39 Transferring Impella 5.0 /Impella LD Supported Patient 44 Impella 2.5 /Impella CP Patient Care Procedures 47 Impella 5.0 /Impella LD Patient Care Procedures 52 Impella 2.5 /Impella CP Catheter Weaning Procedures 56 Impella 5.0 /Impella LD Catheter Weaning Procedures 57 Impella 2.5 /Impella CP Catheter Explant Procedures 59 Impella 5.0 Catheter Explant Procedure 61 Impella LD Catheter Explant Procedure 62 Impella Program Implementation Tools 64 Impella Certification Process for Physicians 65 Impella Certification Process for Advanced Users 66 Impella Skills Checklist/Supply Lists Impella 2.5 or Impella CP Tech Skills 68 Impella 2.5 or Impella CP Circulator Skills 69 Impella 5.0 and Impella LD Scrub Skills 70 Impella 5.0 and Impella LD Circulator or Perfusionist Skills 71 Transfer of Care Impella 2.5 /Impella CP Skills Checklist (peel-away sheath) 72 Transfer of Care Impella 2.5 /Impella CP Skills Checklist (non-peel-away sheath) 73 Impella 2.5 or Impella CP ICU RN Skills 74 Impella 5.0 or Impella LD ICU RN Skills 75 Impella 2.5 /Impella CP Supply List 76 Impella 5.0 /Impella LD Supply List 77 Appendix A: Program Resources 78 References 79

5

6

7 Summary A Protected PCI is an Impella 2.5 and Impella CP device supported heart procedure that maintains hemodynamic stability for a patient, allowing a cardiologist to do a more complete revascularization in a single session. Impella 2.5 and Impella CP is the only percutaneous hemodynamic support device proven safe and effective at reducing peri-procedural and post-procedural adverse events in elective and urgent high-risk patients. In addition, Impella 2.5, Impella CP, Impella 5.0, and Impella LD heart pumps are now FDA indicated to provide treatment of ongoing cardiogenic shock. i

8 ii

9 Introduction Effective Impella heart pump programs are most successful when the program has structure provided by algorithms, protocols and tools for success as well as ongoing training initiatives. The following key components are vital to the successful implementation and growth of an Impella heart pump program: Structure and ownership Implementation and training initiatives Patient management and clinical protocols Impella technology logistics Optimized economics Quality improvement Marketing and public awareness Outreach education The purpose of the Impella Heart Pumps Clinical Protocols and Tools is to provide your hospital with the patient management and clinical protocols that assist programs in launching and maintaining successful program practices. The programs that excel utilize standard protocols and tools while offering continuous training to all members of the multidisciplinary team that is involved in the care of Impella heart pump patients. Abiomed, Inc., the maker of the Impella heart pumps, offers a thorough training program for both physicians and hospital staff. Training covers the full spectrum of therapy, from an overview of the technology, controller, and system set-up and insertion, through patient management topics. Abiomed offers numerous training avenues, including: Clinical support and on-site, hands-on customer training Print and web-based educational materials Quick skills videos Hands-on Automated Impella Controller (AIC) console training 24/7 clinical and technical telephone support through the Emergency Clinical Support Hotline ( ) Advanced programs for more experienced users Physician certification Masters Programs Impella Clinical Expert (ICE) Programs Mobile Learning Laboratories iphone Apps Reimbursement Hotline ( ) Please visit for a full listing of resources available from Abiomed, Inc. iii

10 Protected PCI with Impella 2.5 and Impella CP On March 23, 2015, the Impella 2.5 received PMA approval from the U.S. FDA* and on December 2, 2016 the Impella CP received PMA approval from the U.S. FDA. The clinical data demonstrating Impella 2.5 s safety and effectiveness includes > 1,600 patients from an FDA-randomized, controlled trial and a U.S. multi-center registry, as well as over 200 peer-reviewed publications in the high-risk PCI setting. Impella 2.5 and Impella CP maintains patient hemodynamics during planned temporary coronary occlusions by maintaining mean arterial pressure (MAP), which may allow for a more thorough procedure and a more complete revascularization in a single session. Mean arterial pressure1 Procedural decrease in arterial pressure from baseline2 Mean Arterial Pressure N=543; P < ±18 IABP 2 Vessels Treated 3 Vessels Treated -2.7% IABP -8.5% Impella 22% Pre Impella 1 Vessel Treated 101±20 N= % P <.001 On Impella -7.6% Baseline Protected PCI -14.9% P = % Impella P =.026 MACCE3 Clinical outcomes of the PROTECT II randomized controlled trial demonstrated a 29% reduction in MACCE at 90 days.3 Extensive revascularization was also associated with the largest reduction of adverse events.4 Readmissions from 5 repeat revascularization Cost effectiveness of Impella 2.5 and Impella CP has been demonstrated through a randomized controlled trial, all-payer population based studies, and a systemic review of reduced length of stay. Study observations include fewer readmissions, less days in the hospital, and a better of quality of life through reduced heart failure symptoms. 12% 52% Reduction in repeat revascularization N=427; P =.024 Reduced length of stay Total days in hospital 5 Impella 90 DAYS 6 Total Days in Hospital P = P < days or 22% 8% 58% Reduction in Class III, IV 17% 7.0 6% IABP NYHA class improvement post PCI NYHA class improvement post procedure 18% NYHA Class of heart failure Class IV 45% 30% Class III Class II IABP Impella Median days in hospital; index stay through 90 days, N=427, Readmissions N=208 Class I 31% 44% 7% Baseline 90 days N=223 patients from both arms of PROTECT II trial with NYHA measurements available at baseline and 90 days PROTECT II STUDY Six society clinical guidelines now reference Impella, including ACC/AHA/SCAI/ISHLT/HFSA * The device is indicated for: The Impella 2.5 and Impella CP Systems are temporary ( 6 hours) ventricular support devices indicated for use during high-risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 and Impella CP Systems in these patients may prevent hemodynamic instability, which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events. iv

11 Improving Outcomes in Cardiogenic Shock Impella 2.5, Impella CP, Impella 5.0, and Impella LD heart pumps are now FDA indicated to provide treatment of ongoing cardiogenic shock. In this setting, the Impella heart pumps have the ability to stabilize the patient s hemodynamics, unload the left ventricle, perfuse the end organs, and allow for recovery of the native heart. Impella devices have also been proven to be cost-effective through reduction in length of hospital stay, readmissions, and overall costs compared with alternative treatment. 7 The latest approval adds to the prior FDA indication of Impella 2.5 for elective MAP and urgent high-risk percutaneous coronary intervention (PCI), or Protected PCI. End-Organ Perfusion Identify Cardiogenic Shock Early Systolic blood pressure (SBP) <90 mmhg or on inotropes/pressors Cold, clammy, tachycardia Lactate elevated >2 mmoi/l Cardiogenic Etiology Evaluation EKG (STEMI/NSTEMI) Echocardiography If available, PA catheter, cardiac output, CPO, CI, PCWP, SVO Ischemia Hemodynamic Effects of Impella Support Reverse the Cardiogenic Shock Spiral Cardiac Output Coronary Perfusion Progressive Myocardial Dysfunction Death Spiral of Cardiogenic Shock Myocardial Recovery Patients Reverse Spiral End-Organ Failure Flow Principles of Impella Design cvad Registry 29 MAP Cardiac Output Outflow Inflow (aortic root) (ventricle) 94.4 ± ± 1.7 aortic valve 62.7 ± ± % P< % (n=143) (n=23) MAP LVEDP and LVEDV P< Wall Tension Microvascular Resistance Coronary Perfusion Mechanical Work Pre- Support On Support Cardiac Power Output (MAP x CO x ) 1.06 ± 0.48 Pre- Support PCWP 31.9 ± 11.1 On Support 19.2 ± ± % (n=23) P< % (n=25) P< Cardiac Power Output End-Organ Perfusion O 2 Supply O 2 Demand Unloading to Myocardial Recovery Pre- Support On Support Pre- Support On Support The catheter-based VAD Registry is a worldwide, multicenter, IRB-approved, monitored clinical registry of all patients at participating sites; registry data is used for FDA PMA submissions Early Stabilization Can Improve Outcomes in Cardiogenic Shock Early initiation of hemodynamic support prior to PCI with Impella 2.5 is associated with more complete revascularization and improved survival in the setting of refractory CS complicating an AMI. 29 William W. O'Neill, MD; Theodore Schreiber, MD; David H. W. Wohns, MD; Charanjit Rihal, MD; Srihari S. Naidu, MD; Andrew B. Civitello, MD; Simon R. Dixon, MB, ChB; Joseph M. Massaro, PhD; Brijeshwar Maini, MD; & E. Magnus Ohman, MD. SURVIVAL RATE Day Survival 29 cvad Registry* N=154 Impella Pre-PCI IABP/Inotropes Pre-PCI Log-rank, P = DAYS FROM INITIATION OF IMPELLA Major society clinical guidelines now reference Impella devices, including ACC/AHA/SCAI/ISHLT/HFSA v

12 Clinical Guidelines for Impella Protected PCI with Impella AHA/ACC Guideline for the Management of Patients with Non-ST-elevation Acute Coronary Syndromes 30 Journal of the American College of Cardiology Revascularization in Heart Failure: Class I Revascularization strategy based on the degree, severity, and extent of CAD; cardiac lesions pvads: Large amount of ischemic territory/poor LV function 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention 31 Journal of the American College of Cardiology High-risk patients: Class IIb Class III: HARM without hemodynamic support; for PCI at hospitals without on-site cardiac surgery Additional Guidelines 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Journal of the American College of Cardiology 31 PCI and Cardiogenic Shock: Class I Use of Mechanical Circulatory Support: American Heart Association (2012) 32 Circulation Acutely decompensated heart failure patients: Class IIa 2013 lnt'i Society for Heart & Lung Transplantation Guidelines for Mechanical Circulatory Support 33 The Journal of Heart and Lung Transplantation Temporary mechanical support for patients with multi-organ failure: Class I 2013 ACCF/AHA Guideline for the Management of Heart Failure 34 Circulation "Bridge to Recovery" or "Bridge to Decision" for patients with acute, profound hemodynamic compromise: Class IIa 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 35 Circulation STEMI and Cardiogenic Shock: Class Ib STEMI and Urgent CABG: Class IIa vi

13

14 Impella Heart Pump Clinical Protocols This section includes several templates for Protected PCI with Impella Program protocols. (For more information, contact Sample Protected PCI with Impella Clinical Decision Tree Sample Cardiogenic Shock Algorithm Impella 2.5 and Impella CP Catheter Set-Up Procedure Impella 5.0 and Impella LD Catheter Set-Up Procedure Impella 2.5 and Impella CP Catheter Insertion Procedure Impella 5.0 and Impella LD Catheter Insertion Procedure Impella 2.5 and Impella CP /Impella 5.0 /Impella LD Device Purge System Management Procedures Transfer of Care Impella 2.5 /Impella CP Transfer of Care Impella 5.0 /Impella LD Impella 2.5 /Impella CP Catheter Patient Care Procedure Impella 5.0 /Impella LD Catheter Patient Care Procedure Impella 2.5 /Impella CP Catheter Weaning Procedure Impella 5.0 /Impella LD Catheter Weaning Procedure Impella 2.5 Catheter Explant Procedure Impella 5.0 /Impella LD Catheter Explant Procedure These protocols are a compilation of best practices. Review each protocol with your hospital s committee and customize as needed before putting it into place, keeping in mind your particular institution's policies and procedures concerning the practice of medicine. For the latest product information, refer to the Impella device Instructions For Use (IFU) manuals, available on the Abiomed website: 2

15 Sample Protected PCI with Impella Device Clinical Decision Tree Diagnosis: High-risk patient Treatment Decision Heart Team decision No Medical Management Yes Revascularization Choice of appropriate treatment (PCI vs. CABG) by multidisciplinary Heart team, per Guidelines (Class I) 31 CABG PCI No Hemodynamic support indicated? Yes Hemodynamically stable LVEF 35%, complex CAD with comorbidities - FDA-Approved Indication - Per Guidelines 30,31 Conventional PCI Protected PCI with Impella 2.5 Goal: More Complete Revascularization 3

16 Sample AMI Cardiogenic Shock Algorithm Identify SBP <90 mmhg or on Inotropes/Pressors Cold, clammy, tachycardia Lactate elevated >2 mmol/l Stabilize Early Impella Support pre-pci 29,40,41 Reduce Inotropes/Pressors 42,43 Cardiogenic etiology evaluation EKG (STEMI / NSTEMI) Echocardiography 39 If available, PA Catheter, 8-10 Cardiac Output, CPO, CI, PCWP, SVO 2 Complete Revascularization Per Guidelines 35,44 Assess for Myocardial Recovery (Weaning and Transfer Protocols) Cardiac Output Cardiac Power Output Urine Output Lactate Inotropes Myocardial Recovery No Recovery Escalate (& Ambulate) or Transfer 47 Ongoing Left Heart Failure Assess for Right Heart Failure 4

17 Sample Identify: Minimize Duration of Shock Suspect Cardiogenic Shock See A Confirm CGS Diagnosis reassess every 1-2 hours if criteria not initially met See B Activate Heart Recovery Team/Cardiac Cath Lab Suspect Shock A Consider any of these criteria: Cool, clammy, pale skin Confusion/anxiety Rapid, shallow breathing SBP < 90 mmhg > 30 min Inotrope/vasopressor and/or IABP to maintain SBP > 90 mmhg Decrease in urine output (<0.5cc/kg/hr) Serum Lactate Level > 2 mmol/l Diagnose CGS STEMI/Non-STEMI ECG ST segment abnormalities Troponin ECHO (assess cardiac function) If PA Catheter (PAC) available: Cardiac Index (CI) < 2.2 L/min/m 2 Pulmonary Capillary Wedge Pressure (PCWP) > 18 mmhg Cardiac Power Output (CPO) < 0.6watts B 5

18 Sample Stabilize Early and Complete Revascularization BEST PRACTICE Assess Hemodynamics: LVEDP or PAC If sustained hypotension (SBP < 90 mmhg) for > 30 min Or CI < 2.2 with LVEDP or PCWP >18 mmhg, consider mechanical circulatory support Activate Cardiac Cath Lab Access Assess Hemodynamics Impella 2.5 or CP Begin Weaning Catecholamines* BEST PRACTICE Access: 1. Femoral arterial access using micropuncture with image guidance (ultrasound and/or fluoroscopy) 1 2. Angiography via 4F micropuncture dilator to confirm puncture site & vessel size 3. Place appropriately sized (5 or 6 Fr) arterial sheath 4. Obtain venous access (femoral or internal jugular) If femoral arterial anatomy suitable and no contraindications, place, or escalate to (if IABP already in place), Impella 2.5 or Impella CP * If consistent with overall hemodynamic management Reassess Hemodynamics: PAC (if not done initially) 1. CPO = MAP CO/451 W 2. PAPi = spap-dpap/ra Acute MI? No Yes Coronary Angiogram with PCI PCI: Coronary angiography and PCI with goal of complete revascularization Reassess Hemodynamics 6

19 Sample Reassess Prior to Discharge from Cath Lab Reassess Hemodynamics via PAC prior to Discharge from the Cath Lab: 1. Cardiac Power Output (CPO) MAPxCO / Pulmonary Artery Pulsatility Index (PAPi) spap-dpap/ra CPO < 0.6 CPO > 0.6 PAPi 1.5 > 1.5 PAPi 1.5 > 1.5 RV Dysfunction: Right Sided MCS (Impella RP) RV Preserved: Escalate MCS or consider transfer to LVAD/Transplant Center RV Dysfunction: Right Sided MCS (Impella RP) VA or VV-ECMO: Recommend maintaining Impella at low speed for LV decompression Yes Persistent Hypoxemia? PaO 2 <55 on 100% FiO 2 No Admit to ICU to maximize supportive care and to actively Assess for Myocardial Recovery RV Failure as defined by Recover Right1: CI<2.2 L/min/m2 (despite continuous infusion of 1 high dose inotrope, i.e. DA/Dobutamine 10µg/kg/min or equivalent) and any of the following: 1. CVP>15mmHg or 2. CVP/PCWP or LAP ratio >0.63 or 3. RV dysfunction on TTE (TAPSE score 14mm) 7

20 Sample Escalation, Weaning and Transfer Assess for Myocardial Recovery (At least every 12 hours) Improving Clinical, Echocardiographic & Hemodynamic parameters (concordant): Cardiac output CPO Urine output Lactate Inotropes low dose/discontinued Adequate Ramp test Mixed picture Clinical, Echocardiographic & Hemodynamic parameters (discordant): Some parameters are improving Pressors lowered but not discontinued Fails ramp test Worsening Clinical, Echocardiographic & Hemodynamic parameters (concordant): Cardiac output CPO Urine output Lactate Inotrope dependent Absent pulsatility Myocardial Recovery Inadequate Recovery No Recovery Escalate (& Ambulate) or Transfer Wean & Explant Impella (After a minimum of 48h) Continue Impella Support & frequent clinical reassessment Failure to recover within hours, consider escalation or durable VAD/Transplant See Escalate or Transfer Protocol 8

21 Sample No Recovery: Escalate (& ambulate) or Transfer RV Failure as defined by Recover Right 1 : CI<2.2 L/min/m 2 (despite continuous infusion of 1 high dose inotrope, i.e. DA/Dobutamine 10µg/kg/min or equivalent) and any of the following: 1. CVP>15mmHg or 2. CVP/PCWP or LAP ratio >0.63 or 3. RV dysfunction on TTE (TAPSE score 14mm) No Recovery Escalate (& ambulate) or Transfer Guidance by RHC is Critical CPO remains < 0.6 After 24 hours Worsening/ Not Improving Clinical, Echocardiographic & Hemodynamic parameters (concordant): Cardiac output CPO Urine output Lactate Inotrope dependent Absent pulsatility PAPi 0.9 (RV Failure) PAPi 1.5 (RV dysfunction) PAPi > 1.5 (acceptable RV function) Biventricular support with Impella RP on the right side (transfer if not available) Consider supporting the right side with Impella RP (transfer if not available) Consider left side escalation with Impella 5.0 (transfer if not available) CPO = (MAPxCO)/451 PAPi = spap-dpap/ra 9

22 Impella 2.5 /Impella CP Catheter Set-Up Procedures Purpose Audience Desired Outcomes Equipment Preparation Alerts Procedure To set up the Impella 2.5 or Impella CP Catheters for insertion Healthcare providers involved in setting up the Impella 2.5 and Impella CP Catheters prior to insertion Impella 2.5 or Impella CP Catheter will be ready to insert Automated Impella Controller Impella 2.5 or Impella CP Catheter Insertion kit Diagnostic catheter (6 Fr AL1 or MP without side holes or 5 Fr pigtail with or without side holes) 5-8 Fr Introducer and 10 Fr Dilator Standard 0.035" x 180 cm J-Tip Guidewire 500 ml bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) 500 ml bag of NaCl with pressure bag Back-up Automated Impella Controller, purge cassette, connector cable, and Impella 2.5 or Impella CP Catheter, in the event they are needed Gather supplies and equipment The Li-ion batteries in the Automated Impella Controller must be charged for 5 hours prior to system operation in order to ensure 1 hour of battery operation Dedicated AC power source Do NOT open the Impella 2.5 or Impella CP Catheter tray until you receive confirmation that the physician is proceeding with the insertion based on results of the clinical evaluation of the patient. (For more information, refer to the Pre-Support Evaluation section of the Instructions for Use Manual.) Impella 2.5 and Impella CP Catheter Set-Up Procedure: CASE START Action 1. Performed at Controller: Turn the Automated Impella Controller on. (Screen will advance when completed) 2. Performed at Controller: Press "START NEW CASE" soft key. (Screen will advance when completed) Notes Press and hold the black power switch found on the right side of the controller for 3 seconds. Screen reads "Anticoagulate once sheath is in". 3. Performed in Sterile Field: Open purge cassette in sterile field. Pass spike and cassette off sterile field. 4. Performed at Controller: STEP 1: Spike Dextrose Bag Press NEXT soft key (Screen will advance when completed) D5W recommended. If D5W supplied in bottles, open the vent on the purge fluid spike and proceed. (continued) 10

23 5. Performed at Controller: STEP 2: a) Open front purge cassette door using button on left side. b) Insert purge cassette and disc then close door. (Screen will advance when completed) Button located on left side of controller screen. Insert cassette first, then slide disc in, with flat side inward. 6. Performed in sterile field: Open Impella Catheter and cable in sterile field. Pass white, round end of cable off sterile field. 7. Performed simultaneously: STEP 3: a) Connect white cable to Impella catheter: connect grey end arrow to arrow. b) Connect white end to Controller. (Screen will advance when completed) Performed in sterile field. Performed at Controller. 8. Performed in sterile field: STEP 4: a) Snap on purge clip. b) Connect purge tubing to Impella catheterusing luers: Yellow to Yellow Red to Red (Screen will advance when completed) 9. Performed in sterile field: STEP 5: Squeeze and hold sides of white flush valve until controller beeps. (Screen will advance when completed) 10. Performed at Controller: STEP 6: Confirm Purge Fluid information. Press ACCEPT soft key if no change. Press EDIT soft key to change information. Turn the selector knob to each individual value. Press the selector knob to open options. Scroll to desired value and press selector knob to confirm value. Continue procedure until all values are selected. Select OK by pressing selector knob. (Screen will advance when completed) 11. Performed at Controller: DO NOT press "START Impella" soft key until Physician confirms successful insertion, proper position and removal of guidewire from catheter. Read alerts on controller screen. Confirm that appropriate steps are taken, then: Connects purge lines to catheter cable. Luers attach purge tubing to matching side-arm ports. Squeeze continuously until beep sounds. Use selector knob to EDIT information. "Priming Impella " screen may appear if still priming. (Screen will advance when completed) Confirm anticoagulation. Confirm Purge Fluid exit. Confirm Guidewire removal. (continued) 11

24 Follow-up Proceed with Impella 2.5 or Impella CP Catheter insertion. References (Supportive Data) Impella 2.5 or Impella CP Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 12

25 Impella 5.0 /Impella LD Catheter Set-Up Procedures Purpose Audience Desired Outcomes Equipment Preparation Alerts Procedure To set up the Impella 5.0 or Impella LD Catheter for insertion Healthcare providers involved in setting up the Impella 5.0 or Impella LD Catheter prior to insertion Impella 5.0 or Impella LD Catheter will be ready to insert Automated Impella Controller Impella 5.0 or Impella LD Catheter Insertion kit 500 ml bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) Back-up Automated Impella Controller, purge cassette, connector cable, and Impella 5.0 and Impella LD Catheter, in the event they are needed Impella 5.0 only: Diagnostic catheter (6 Fr AL1 or MP without side holes or 5 Fr pigtail with or without side holes) Standard 0.035" x 180 cm J-Tip Guidewire Additional equipment for Axillary insertion of Impella 5.0 : Axillary Insertion Kit Dacron vascular graft 10 mm x 20 cm Impella LD Dacron vascular graft 10 mm x 15 cm Gather supplies and equipment The Li-ion batteries in the Automated Impella Controller must be charged for 5 hours prior to system operation in order to ensure 1 hour of battery operation Dedicated AC power source Do NOT open the Impella 5.0 and Impella LD Catheter until you receive confirmation that the physician is proceeding with the insertion based on results of the clinical evaluation of the patient. (For more information, refer to the Pre-Support Evaluation section of the Instructions for Use Manual.) Impella 5.0 and Impella LD Catheter Set-Up Procedure: CASE START Action 1. Performed at Controller: Turn the Automated Impella Controller on. (Screen will advance when completed) Notes Press and hold the black power switch found on the right side of the controller for 3 seconds. 2. Performed at Controller: Press "START NEW CASE" soft key. (Screen will advance when completed) 3. Performed in sterile field: Open purge cassette in sterile field. Pass spike and cassette off sterile field. (continued) 13

26 4. Performed at Controller: STEP1: Spike Dextrose bag Press "Next" soft key (Screen will advance when completed) D5W recommended. If D5W supplied in bottles, open the vent on purge fluid spike and proceed. 5. Performed at Controller: STEP 2: a) Open front purge cassette door using button on left side. b) Insert purge cassette and disc then close door. (Screen will advance when completed) 6. Performed in sterile field: Open Impella Catheter and cable in sterile field. Pass white, rounded end of cable off sterile field. 7. Performed simultaneously: STEP 3: a) Connect white cable to Impella catheter: connect gray end arrow to arrow b) Connect white end to controller (Screen will advance when completed) 8. Performed in sterile field: STEP 4: a) Snap on purge clip. b) Connect purge tubing to Impella Catheter using luer: yellow to yellow (Remove and discard Y-Connector) (Screen will advance when completed) 9. Performed at Controller: STEP 5: Confirm Purge Fluid information Press ACCEPT soft key if no change Press EDIT soft key to change information. Turn the selector knob to each individual value. Press the selector knob to open options. Scroll to desired value and press selector knob to confirm value. Continue procedure until all values are selected. Select OK by pressing selector knob. 10. Performed at Controller: DO NOT press Flow Control soft key until physician confirms successful insertion, proper position and removal of Guidewire from Impella 5.0 Catheter. Read alerts on controller screen. Confirm that appropriate steps are taken. Button located on left side of controller screen. Insert cassette first, then slide disc in, with flat side inward. Performed in sterile field. Performed at Controller. Connects purge lines to catheter cable. Luer attaches purge tubing to matching side-arm port. Use selector knob to EDIT information. "Priming Impella " screen may appear if still priming. (Screen will advance when completed) Confirm alerts associated with specific device. (continued) 14

27 Follow-up Proceed with Impella 5.0 or Impella LD Catheter insertion. References (Supportive Data) Impella 5.0 or Impella LD Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 15

28 Impella 2.5 /Impella CP Catheter Insertion Procedures Purpose To insert the Impella 2.5 or Impella CP Catheter Audience Healthcare providers involved in the insertion of the Impella 2.5 and Impella CP Catheter Desired Outcomes Impella 2.5 or Impella CP will be successfully inserted and provide hemodynamic support to the patient Equipment The following equipment will be in place from the Impella 2.5 and Impella CP Catheter Set-Up Procedure: Automated Impella Controller Impella 2.5 and Impella CP Catheter set-up and insertion kit Diagnostic catheter (6 Fr AL1 or MP without side holes or 5 Fr pigtail with or without side holes) 5-8 Fr introducer and 10 Fr Dilator Standard 0.035" x 180 cm J-Tip Guidewire 500 ml bag of NaCl with pressure bag 500 ml bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) Back-up Automated Impella Controller, purge cassette, connector cable, and Impella 2.5 and/or Impella CP Catheter, in the event they are needed Preparation Gather supplies Dedicated AC power source Alerts Fluoroscopy is required to guide placement of the Impella 2.5 and Impella CP Catheter. The small placement guidewire must be reliably observed at all times. Remove the placement guidewire prior to turning the Impella 2.5 and Impella CP Catheter on. Avoid manual compression of the Impella 2.5 and Impella CP Catheter inlet or outlet areas. Maintain ACT at seconds during support. Retrograde flow may occur across the aortic valve if the Impella 2.5 and Impella CP Catheter is set at a performance level below P-2. Procedure Inserting the Impella 2.5 or Impella CP Catheter (Wired Insertion Technique ) Action Notes 1. Obtain access to femoral artery. 2. Insert 5 8 Fr introducer over the 0.035" guidewire. 3. Remove 5 8 Fr introducer over 0.035" guidewire. Predilate the artery with a 10 Fr dilator prior to inserting the 13 Fr or 14 Fr peel-away introducer with dilator. While inserting the introducer, hold the shaft of the introducer to slide it into the artery. (continued) 16

29 4. Administer Heparin. When ACT is 250 seconds or above, remove the dilator. 5. Insert diagnostic catheter (Abiomed recommends using a 5 Fr pigtail with or without side holes or 6 Fr AL1 or MP without side holes) over a 0.035" diagnostic guidewire into the introducer and advance it into the left ventricle. When using a pigtail with side holes, magnify the area one to two times as the guidewire begins to exit the pigtail to ensure that the guidewire exits the end of the catheter and not the side holes. To do so, magnify the area one to two times as the guidewire begins to exit the pigtail. 6. Remove the 0.035" diagnostic guidewire, leaving the diagnostic catheter in the ventricle. Form a curve or bend on the end of the inch x 260 cm placement guidewire, following the instructions. Bend the shaping ribbon against the tool, using minimal force. Do not use a shaping tool with a sharp tip or edge. Do not pull the shaping tool along the length of the shaping ribbon as this could strip the coil off the guidewire and cause it to unfurl and separate. Inspect the coil and guidewire for damage after shaping and before using. 7. Advance the placement guidewire into the apex of the left ventricle. 8. Remove the diagnostic catheter. To backload the catheter using the EasyGuide lumen: 9. Insert the placement guidewire into the red EasyGuide lumen at the tip of the pigtail of the Impella 2.5 and Impella CP Catheter. If catheter does not have a red EasyGuide lumen, follow the procedure outlined in step 10. a) Advance the guidewire until it exits the red lumen near the label. b) Remove the red EasyGuide Lumen by gently pulling the label in line with the catheter shaft while holding the Impella 2.5 and Impella CP Catheter. c) If you suspect that a portion of the red lumen remains in the catheter, do NOT use the Impella 2.5 and Impella CP device Catheter. Measure red lumen length using catheter markings (intact length is between 21.5 cm and 22.5 cm). d) Skip to step 11 if the catheter is successfully backloaded on the guidewire. (continued) 17

30 To backload the catheter without the EasyGuide lumen: 10. Wet the cannula with sterile water and backload the catheter onto the placement guidewire. One or two people can load the catheter on the guidewire. One-person technique: a) Advance the guidewire into the Impella 2.5 or Impella CP Catheter and stabilize the cannula between the fingers. This prevents pinching of the inlet area. The guidewire must exit the outlet area on the inner radius of the cannula and align with the straight black line on the catheter. The cannula can be hyperextended as necessary to ensure the guidewire exits on the inner radius of the cannula. Two-person technique: b) The scrub assistant can help stabilize the catheter by holding the catheter proximal to the motor. This will allow the implanting physician to visualize the inner radius. The guidewire must exit the outlet area on the inner radius of the cannula and align with the straight black line on the catheter. The physician can focus on advancing the guidewire and, if the cannula needs to be hyperextended, the scrub assistant is available to assist. 11. Advance the catheter through the hemostatic valve into the femoral artery and along the placement guidewire and across the aortic valve using a fixed-wire technique. Follow the catheter under fluoroscopy as it is advanced across the aortic valve, positioning the inlet area of the catheter 3.5 cm below the aortic valve annulus and in the middle of the ventricular chamber, free from the mitral valve chordae. Be careful not to coil the guidewire in the left ventricle. Be careful not to coil the guidewire in the left ventricle. While inserting the Impella 2.5 or Impella CP Catheter, push the catheter from a few centimeters behind the hub of the peel-away introducer. This prevents the catheter from buckling during insertion. Do not touch inlet or outlet areas. 12. Remove the placement guidewire. 13. Confirm position with fluoroscopy and confirm that an aortic waveform is displayed on the Automated Impella Controller. (continued) 18

31 Procedure Wireless Insertion of the Impella 2.5 and Impella CP Catheters 1. Place the provided 13 Fr introducer in the usual manner. 2. Administer Heparin. When the ACT is above 250 seconds, remove the 13 Fr or 14 Fr dilator. 3. Straighten the pigtail at the end of the Impella 2.5 and Impella CP Catheter by hand and advance it through the hemostatic valve. Advance the catheter in small steps to avoid kinking. The Impella 2.5 or Impella CP Catheter must be visualized at all times. Do not apply excessive force on the catheter when advancing it across the aortic valve. The spring characteristics and robust catheter design should make it easy for the catheter to cross the aortic valve and move into position. 4. Track the catheter through the descending aorta using fluoroscopy. Maintain the pigtail curve on the medial aspect of the aorta closer to the spine. 5. When the pigtail reaches the aortic valve, rest the pigtail against the medial cusp and continue to advance it until the catheter begins to prolapse. 6. Pull back while turning the catheter clockwise, allowing it to advance ( pop ) across the aortic valve. DO NOT apply excessive force on the catheter when crossing the aortic valve. It should be easy for the catheter to cross the aortic valve and move into position. 7. If the catheter fails to advance across the valve, pull back, twist 45 degrees and repeat the process. If the catheter must be removed from the patient, carefully rinse the catheter with Heparinized saline solution in a new, sterile basin to prevent blood from clotting in it when exposed to air. Use a new sterile basin to ensure the catheter will not come in contact with any loose fibers on the sterile field that could interfere with motor operation. (continued) 19

32 Procedure Positioning and Starting the Impella 2.5 or Impella CP Catheter 1. Place the catheter plug at the level of the patient's heart. 2. Prior to starting the pump, reconfirm that the placement guidewire has been removed. Also reconfirm that the controller displays an aortic waveform and the radiopaque marker band is located at the aortic valve annulus. 3. Press the FLOW CONTROL soft button to open the menu. Start Pump is highlighted in blue. Press the selector knob to select Start Pump and the controller starts in AUTO, which automatically increases the flow rate over 30 seconds. AUTO increases the flow rate over a period of up to 30 seconds to the maximum possible flow without causing suction. NOTE: BOOST maximizes the Impella 2.5 or Impella CP Catheter flow for 5 minutes and then returns to the AUTO setting or P Once the controller has begun to run in AUTO, pressing the FLOW CONTROL soft button will open other options: BOOST, P-levels ranging from P-0 to P Wait 30 seconds for flow to reach its maximum value, then confirm correct and stable placement. Evaluate the catheter position in the aortic arch and remove any excess slack. The catheter should align with the lesser curvature of the aorta rather than the greater curvature. Verify placement with fluoroscopy and with the placement signal screen. When the Impella 2.5 or Impella CP Catheter is not correctly placed, there is no effective unloading of the ventricle. The patient may not be benefiting from the flow rate shown on the controller. 6. Reposition the catheter as needed. 7. If the Impella 2.5 or Impella CP Catheter advances too far into the left ventricle and the controller displays a ventricular waveform rather than an aortic waveform, follow these steps to reposition the catheter: a) With fluoroscopy guidance, pull the catheter back until an aortic waveform is present on the placement screen. b) When the aortic waveform is present on the placement screen, you may need to pull the catheter back an additional 4 cm. (The distance between adjacent markings on the catheter is 1 cm.) The catheter should now be positioned correctly. (continued) 20

33 Procedure Handling Low Flows or Suction at Start-Up Follow these steps if the Impella 2.5 and Impella CP Catheter has sudden low flows or suction at startup 1. Obtain Echo to assess for: LV Thrombus RV Failure Hypovolemia 2. If above causes are eliminated, remove the catheter from the patient and ensure that ACT is 250 seconds or above. 3. Closely inspect the inlet and outlet areas and remove any thrombus or other foreign materials. 4. If materials have been removed, run the Impella 2.5 and Impella CP at P-8 or AUTO in a sterile basin. 5. If flows are adequate, re-insert the Impella 2.5 and Impella CP Catheter into the patient. 6. If no material is visible or if the flows are still low, there could be a clot inside the device. The echo assessment of the left ventricle is used to rule out left ventricular thrombus before inserting another device. Follow-up Once the patient is on Impella 2.5 and Impella CP heart pump support, refer to Impella 2.5 and Impella CP patient support procedures. References (Supportive Data) Impella 2.5 or Impella CP Catheters with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 21

34 Impella 5.0 Catheter Insertion Procedure Purpose Audience Desired Outcomes Equipment Preparation Alerts Procedure To insert the Impella 5.0 Catheter Healthcare providers involved in inserting the Impella 5.0 Catheter Impella 5.0 will be successfully implanted and provide hemodynamic support to the patient The following equipment will be in place from the Impella 5.0 Catheter set-up procedure: Automated Impella Controller Impella 5.0 Catheter insertion kit 500 ml bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) Impella 5.0 only: Diagnostic catheter (6 Fr AL1 or MP without side holes or 5 Fr pigtail with or without side holes) Standard 0.035" x 180 cm J-Tip Guidewire Additional equipment for Axillary insertion of Impella 5.0 Axillary Insertion Kit Dacron vascular graft 10 mm x 20 cm Back-up Automated Impella Controller, purge cassette, connector cable, and Impella 5.0 Catheter, in the event they are needed Complete Impella 5.0 Catheter Set-Up Procedure Fluoroscopy is required to guide placement of the Impella 5.0 Catheter. The small placement guidewire must be reliably observed at all times. Avoid manual compression of the inlet, outlet, or sensor areas of the cannula assembly. Do not kink or clamp any part of the Impella 5.0 Catheter. Handle with care. The Impella 5.0 Catheter can be damaged during removal from packaging, preparation, insertion, or removal. Do not bend, pull, or place excess pressure on the Catheter or mechanical components at any time. Be sure to remove the placement guidewire before turning the Impella 5.0 Catheter on. Maintain ACT seconds during support. Retrograde flow may occur across the aortic valve, if the Impella 5.0 Catheter is set at a P-Level below P-2. Inserting the Impella 5.0 Catheter (Via Femoral Artery) Action Notes 1. Identify the femoral artery and perform a cut-down of 3-5 cm. 2. Expose the femoral artery. Wrap vessel loops, one distal and one proximal, to the subsequent point of incision, one and onehalf times around the artery. Make the vessel loops as far apart as possible. (continued) 22

35 3. To prepare the repositioning sheath, remove the luer plug at the end of the side-arm tube and flush the tube with 0.9% NaCl solution. 4. Make the incision as close as possible to the distal loop. Insert a 6 Fr diagnostic catheter without side holes (MP or AL1 without side holes recommended) over a diagnostic 0.035" or 0.038" guidewire into the left ventricle. 5. Remove the diagnostic guidewire, and exchange it for the supplied 0.025" placement guidewire. 6. Hold tension on the proximal loop to prevent bleeding. Straighten the blue pigtail and thread it over the 0.025" placement guidewire. Wet the cannula with sterile water and backload the catheter onto the placement guidewire. One or two people can load the catheter on the guidewire. a) One-Person Technique: Advance the placement guidewire into the Impella 5.0 Catheter and stabilize the cannula between the fingers. This prevents pinching of the inlet area. The placement guidewire must exit the outlet area on the inner radius of the cannula and align with the straight black line on the catheter. The catheter can be hyperextended as necessary, to ensure the placement guidewire exits on the inner radius of the cannula. b) Two-Person Technique: The scrub assistant can help stabilize the catheter by holding the catheter proximal to the motor. This will allow the Implanting Physician to visualize the inner radius. The placement guidewire must exit the outlet area on the inner radius of the catheter and align with the straight black line on the catheter. The physician can focus on advancing the placement guidewire and, if the cannula needs to be hyperextended, the scrub assistant is available to assist. 7. Make a transverse incision at the guidewire for the 21 Fr catheter. Use U-Stitches instead of Purse String sutures to avoid stenosis of the vessel after explantation. 8. Administer Heparin and achieve ACT goal of at least 250 seconds. If patient is receiving a GP IIb/IIIa inhibitor, the Impella can be inserted when ACT is 200 or above. 9. Insert the catheter into the vessel and advance along the 0.025" placement guidewire until resistance is met at the proximal vessel loop. 10. Loosen the proximal loop and advance the catheter into the vessel. When the motor housing is entirely past the proximal vessel loop, temporarily tighten the loop to control bleeding. (continued) 23

36 11. Advance the repositioning sheath, located on the catheter shaft, through the incision and into the femoral artery until bleeding is controlled. Secure the sheath outside of the vessel using the supplied suture loop. While feeding the Impella 5.0 Catheter through the femoral artery, hold the device at the cannula or motor housing. Do not touch the inlet area or outlet area. 12. Stabilize the guidewire and repositioning sheath and advance the catheter through the sheath. Follow the catheter, under fluoroscopy, as it is advanced into the left ventricle. If the Impella 5.0 Catheter is used in the OR as part of Open Heart Surgery, manipulation may be performed only through the 9 Fr steering catheter. Direct manipulation of the catheter through the aorta or ventricle may result in serious damage to the Impella 5.0 Catheter and serious injury to the patient. 13. When the catheter is correctly positioned, slightly loosen the proximal vessel loop and remove the 0.025" guidewire. Leave at least 2 to 3 cm of the repositioning sheath inside the vessel. 14. Tighten the prepared U-Stitches to seal the sheath. 15. Loosen the distal loop. Then loosen the proximal vessel loop. 16. After the incision is closed, advance the sterile sleeve and attach to the repositioning sheath. Secure the Impella 5.0 Catheter by tightening the Tuohy- Borst valve. (continued) 24

37 Procedure Inserting the Impella 5.0 Catheter Via Axillary Artery 1. Open sterile Axillary Insertion Kit. Open sterile Dacron vascular graft 10 mm x 20 cm (not supplied in kit). Kit contains: Short 23 Fr peel-away sheath with hemostatic value 2 graft locks (to facilitate fixation of 10 mm vascular graft to sheath) 8 Fr silicone coated dilator 2. Expose axillary artery in the subclavian fossa. Use proximal and distal vessel loops to obtain control. 3. A longitudinal arteriotomy is fashioned and the degree beveled, 10 mm vascular graft is anastomosed to the axillary artery using a standard end-to-side anastomosis. 4. Clamp graft with soft-jawed clamp just above the anastomosis. Loosen the vessel loops to assess for hemostasis at the anastomosis. 5. Flush the side-arm of the peel-away sheath. Insert the provided peel-away sheath into the end of the graft. 6. Use graft lock(s) to attach the graft to the proximal end of the sheath. If hemostasis is not achieved, press the two tabs together until fully engaged. Place graft lock between the hub and the retainers to prevent introducer migration. Graft may also be secured to the introducer using Number 2 sutures or umbilical tape. 7. Remove soft-jawed clamp from graft 8. Insert 0.035" guidewire and 6 Fr diagnostic catheter through the center of the hemostatic valve, of the peel-away sheath, and advance across the aortic valve under fluoroscopic guidance. 9. Exchange the 0.035" guidewire for the supplied 0.018" placement guidewire. 10. Remove the diagnostic catheter, leaving the 0.018" guidewire in place. 11. Clamp the graft, near the anastomosis, using the softjawed clamp. 12. Advance silicone-coated dilator over the 0.018" guidewire, into the hemostatic valve, then remove. Clamping the graft prevents bleeding through the cannula during initial Impella 5.0 Catheter advancement across the hemostatic valve. Lubrication of the hemostatic valve with silicone facilitates catheter insertion. (continued) 25

38 13. Advance Impella 5.0 Catheter over the 0.018" guidewire into the sheath. Ensure soft-jawed clamp is in place to prevent bleeding through the device as it passes through hemostatic valve. 14. Remove the soft-jawed clamp once the motor housing is within the graft. 15. Advance Impella 5.0 Catheter into the left ventricle under fluoroscopic guidance. 16. Remove guidewire prior to starting Impella support. 17. Begin Impella support by increasing P-Level on Automated Impella Controller. 18. Re-apply the soft-jawed clamp to graft above the anastomosis and distal to the tip of the sheath, sealing over the 9 Fr catheter shaft of the Impella 5.0 Catheter. Ensure a tight seal by opening the side-arm flush valve of the sheath. 19. Remove the graft locks. 20. Withdraw peel-away sheath from graft and peel away. 21. Shorten the graft as desired. Tighten vessel loops to allow removal of softjawed clamp Shorten graft so that graft material will not be exposed once the incision is closed. 22. Advance the repositioning Unit into the graft and secure, using suture ties along the suture ribs on the proximal end of the Repositioning Sheath. 23. Close the subcutaneous tissue and skin. Secure blue suture wings to the skin. 24. Advance the sterile sleeve and to the repositioning sheath. Secure the Impella 5.0 Catheter by tightening the Tuohy- Borst valve. (continued) 26

39 Procedure Starting the Impella 5.0 Catheter 1. Press FLOW CONTROL soft key 2. Turn selector knob to increase the P-Level from P-0 to P-2. Press selector knob to confirm selection. 3. Confirm appropriate increase in Impella Flow. 4. Press FLOW CONTROL and turn selector knob with each P-Level increase and press selector knob to confirm selection. 5. Evaluate catheter position in the aortic arch and remove any excess slack. Verify placement with fluoroscopy and the Placement Signal Screen. Follow-up Refer to Patient Care Procedures. References (Supportive Data) Impella 5.0 or Impella LD Catheters with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 27

40 Impella LD Catheter Insertion Procedure Purpose Audience Desired Outcomes Equipment Alerts Procedure To insert the Impella LD Catheter Healthcare providers involved in inserting the Impella LD Catheter Impella LD will be successfully implanted and provide hemodynamic support to the patient The following equipment will already be in place from the Impella LD Catheter set-up procedure: Automated Impella Controller Impella LD Catheter insertion kit 500 cc bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) Dacron vascular graft 10 mm x 15 cm Back-up Automated Impella Controller, purge cassette, connector cable, and Impella LD Catheter, in the event they are needed Transesophageal Echocardiography (TEE) is required for placement of the Impella LD Catheter. It is important to make the incision, in the ascending aorta, 7 cm above the aortic valve so that the Impella LD Catheter can be positioned properly. An incision too close to the aortic valve annulus could result in the catheter outlet area in the graft rather than the aorta. The incision must be 6 mm in length to prevent the front silicone plug from advancing into the aorta through the incision. Insertion of the Impella LD Catheter Action Notes 1. Using the supplied sterile incision template for positioning, place a side biter clamp on the aorta at least 7 cm above the valve plane. 2. Make an incision (or punch) no larger than 6 mm at the insertion site on the ascending aorta. 3. Attach the Dacron vascular graft (10 mm x 15 cm) to the aorta using the standard end-toslide anastomosis. 4. Administer Heparin and achieve ACT of at least 250 seconds. If the patient is receiving a GP IIb/lIIa inhibitor, the Impella LD Catheter can be inserted when ACT is 200 seconds or above. 5. When the anastomosis is complete, place a clamp at the distal end of the graft and then release the proximal clamp at the base of the graft. Examine the suture line for leaks and re-clamp the graft at the base. 6. Moisten the Impella LD Catheter and push both silicone plugs up against the motor housing. (continued) 28

41 7. With the graft clamped at the base, place the Impella LD Catheter into the open end of the graft up to the level of the rear plug. 8. When the catheter is in position, secure a tourniquet around the rear silicone plug. Tighten the tourniquet sufficiently to control bleeding around the rear plug while still allowing the catheter to slide through the plug. 9. Release the clamp and advance the Impella LD Catheter into the aorta. 10. If the patient is on cardiopulmonary bypass (CPB), allow the heart to fill by restricting the return flow to the bypass machine and reducing CPB flow to a minimum setting, as long as acceptable physiologic systemic flow is maintained. The aortic valve must be opening during the cardiac cycle to allow the Impella LD to pass. 11. As soon as the motor housing has passed into the aorta, the initial placement signal will be dampened. The inlet area of the catheter has not passed the aortic valve. Do not allow the front plug to advance beyond the base of the graft. 12. To aid in passing the catheter through the aortic valve, apply slight pressure to the posterior aspect of the aortic valve to produce temporary aortic insufficiency. 13. Gently advance the catheter forward until the tip of the inlet area of the Impella LD Catheter is approximately 4 cm below the aortic valve. 14. Position the front silicone plug as close as possible above the aorta. Secure the silicone plug to the graft using a penetrating suture ligature. When securing the silicone plug to the graft, ensure that the penetrating suture does not go all the way through the silicone plug and damage the catheter. 15. After achieving correct and stable placement, clear the vascular graft of excess blood and re-secure the rear silicone plug to the end of the graft. 16. When closing the skin incision, the sternum may or may not be closed, per surgeon. Left heart structures should not be opened when the catheter is in place in the left ventricle. Do not cross-clamp the aorta when the Impella LD Catheter is in place. The catheter must be pulled back into the descending aorta prior to cross-clamp. (continued) 29

42 Procedure Starting the Impella LD Catheter 1. Press FLOW CONTROL soft key. 2. Turn selector knob to increase the P-Level from P-0 to P-2. Press selector knob to confirm selection. 3. Confirm appropriate increase in Impella Flow. 4. Press FLOW CONTROL and turn selector knob with each P-Level increase and press selector knob to confirm selection. 5. Evaluate catheter position with Echocardiography and the Placement Signal Screen. Follow-up Refer to Patient Care Procedures. References (Supportive Data) Impella 5.0 or Impella LD Catheters with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 30

43 Impella 2.5 /Impella CP Purge System Management Procedures Purpose To maintain the Impella 2.5 or Impella CP purge system Audience Healthcare providers involved in the care of patients supported with the Impella 2.5 or Impella CP Catheter and Automated Impella Controller Desired Outcomes Maintain purge system function of the Impella 2.5 or Impella CP Catheter and Automated Impella Controller Equipment Automated Impella Controller Additional purge cassettes for the Automated Impella Controller 500 ml bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) Preparation Gather supplies prior to beginning Purge System sequence Alerts When replacing the purge cassette, the process must be completed within 2 minutes. The Impella 2.5 or Impella CP Catheter may be damaged if replacement takes longer than 2 minutes. Procedure Change Purge System (changing both purge cassette and purge fluid) Action Notes 1. Press PURGE SYSTEM and turn the selector knob to select Change Purge System from the menu. Press the selector knob to confirm selection. 2. Open the new purge cassette package. If the system is in the standard configuration (connected to the 0.9% NaCl bag), disconnect the Y connector from the purge cassette tubing and discard. 3. Spike the D5W bag/bottle. If the purge solution is supplied in bottles, open the vent on the purge tubing spike and proceed. 4. Turn the Selector Knob to select OK and press selector knob to confirm a bolus to the pressure reservoir. A blue bar shows the progress of the bolus. When the bolus is delivered, the controller advances to the next screen. 5. Disconnect the yellow luer from the Impella 2.5 or Impella CP Catheter, then, remove the used purge cassette from the controller. Open the front door of the controller by pressing button on left side of controller. (continued) 31

44 6. Insert the new purge cassette into the controller. The system will automatically prime the purge cassette and tubing. Close controller door. Slide the purge cassette transmitter, flatside inward, into place and extend the purge tubing through the gap in door. 7. A blue bar shows the progress of the priming. When complete, you are prompted to connect the purge tubing to the Impella 2.5 or Impella CP Catheter. 8. Connect the yellow luer on the end of the purge tubing to the yellow luer on the Impella 2.5 or Impella CP Catheter. 9. Purge system change is complete. Enter the purge fluid values. a) To select the default purge fluid values: The controller will use the default values if no other selections are made. Turn the selector knob to select OK. Press the selector knob to confirm selection. The controller will advance to main operating screen. b) To change the purge fluid values: Turn the selector knob to each individual value. Press the selector knob to open options. Scroll to desired value and press selector knob to confirm value. Continue procedure until all values are selected. Select OK by pressing selector knob. The controller will advance to main operating screen. Procedure Change Purge Fluid (Fluid only) 1. Press PURGE SYSTEM and turn the selector knob to select Change Purge Fluid from the menu. Press the selector knob to confirm selection. 2. Turn the selector knob to select OK and press selector knob to confirm a bolus to the pressure reservoir. A blue bar shows the progress of the bolus. When the bolus is delivered, the Controller advances to the next screen. 3. Clamp the purge tubing before removing the D5W bag/bottle. 4. Replace the D5W bag/bottle and unclamp the purge tubing. If the purge solution is supplied in bottles, open the vent on the purge tubing spike and proceed. 5. Press the selector knob to select OK to complete bag change. Purge system will begin operating. (continued) 32

45 6. Enter Purge Fluid Values To select default purge fluid values: Turn the selector knob to select OK. Press the selector knob to confirm selection. The controller will advance to the next screen. To change purge fluid values: Turn the selector knob to each individual value. Press the selector knob to open options. Scroll to the desired value and press selector knob to confirm value. Continue procedure until all values are selected. Select OK by pressing selector knob. The controller will advance to next screen. 7. Next screen provides option to flush fluid through the purge cassette. To flush cassette: Turn selector knob to select OK. (Proceed to Step 8 below.) To skip flush: Press EXIT. (Procedure complete.) The controller will use default values if no other selections are made. It may be helpful to flush fluid through the purge cassette when changing Dextrose concentration or Heparin concentration. 8. To flush fluid through the purge cassette: Turn the selector knob to select OK and press selector knob to confirm a bolus to the pressure reservoir. A blue bar shows the progress of the bolus. When the bolus is delivered, the controller advances to the next screen. Disconnect the yellow luer from the Impella 2.5 or Impella CP Catheter. Turn the selector knob to select OK. Press the selector knob to confirm flush. When flush is complete, connect the yellow luer to the Impella 2.5 or Impella CP Catheter (Or press BACK to repeat flush, then connect yellow luer). Procedure De-Air the Purge System Action Notes 1. Press PURGE SYSTEM and turn the selector knob to select De-air Purge System. Press selector knob to confirm selection. 2. Confirm that purge fluid bag/bottle is NOT empty or inverted and that tubing is NOT clamped. 3. Disconnect the yellow luer of the purge tubing from the Impella 2.5 or Impella CP Catheter. 4. Press OK to initiate the de-air function. Once complete, the controller advances to the next screen. 5. Confirm that no air remains in the purge tubing. If air remains, press BACK to repeat the air removal process. 6. Connect the yellow luer to the Impella 2.5 or Impella CP Catheter to complete the de-air procedure. (continued) 33

46 Procedure Change Purge Cassette Action Notes 1. Press PURGE SYSTEM and turn selector knob to select Change Purge Cassette from the menu. Press the selector knob to confirm selection. This procedure is only available if the Automated Impella Controller detects a defective purge cassette, purge pressure is low, or the purge system is open. 2. Open the new purge package. 3. Disconnect the yellow luer from the Impella 2.5 or Impella CP Catheter, then remove the used purge cassette from the controller. 4. Spike the D5W fluid bag/bottle If the purge solution is supplied in bottles, open the vent on the purge tubing spike and proceed. 5. Insert the new purge cassette into the controller. 6. The system will automatically prime the purge cassette. Once complete, you will be prompted to connect the yellow luer of the purge tubing to the Impella 2.5 or Impella CP Catheter. 7. Once the luer is connected, press OK to exit the procedure. Controller will advance to main operating screen. Follow-up Impella 2.5 or Impella CP Heart Pump Purge System change per hospital protocol. References (Supportive Data) Impella 2.5 or Impella CP Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 34

47 Impella 5.0 /Impella LD Purge System Management Procedures Purpose To maintain the Impella 5.0 or Impella LD purge system Audience Healthcare providers involved in the care of patients supported with the Impella 5.0 or Impella LD Catheter and Automated Impella Controller Desired Outcomes Maintain purge system function of the Impella 5.0 or Impella LD Catheter and Automated Impella Controller Equipment Automated Impella Controller Additional purge cassettes for the Automated Impella Controller 500 cc bag of D5W (5% recommended; 5% to 40% acceptable) with 50 IU/mL Heparin (recommended) Preparation Gather supplies prior to beginning Purge System sequence Alerts When replacing the purge cassette, the process must be completed within 2 minutes. The Impella 5.0 or Impella LD Catheter may be damaged if replacement takes longer than 2 minutes Procedure Change Purge System (changing both purge cassette and purge fluid) Action Notes 1. Press PURGE SYSTEM and turn the selector knob to select Change Purge System from the menu. Press the selector knob to confirm selection. 2. Open the new purge cassette package. Disconnect the Y-Connector from the purge cassette tubing and discard. 3. Spike the D5W bag/bottle. If the purge solution is supplied in bottles, open the vent on the purge tubing spike and proceed. 4. Turn the Selector Knob to select OK and press selector knob to confirm a bolus to the pressure reservoir. A blue bar shows the progress of the bolus. When the bolus is delivered, the controller advances to the next screen. 5. Disconnect the yellow luer from the Impella 5.0 or Impella LD Catheter, then, remove the used purge cassette from the controller. Open the front door of the controller by pressing button on left side of controller. (continued) 35

48 6. Insert the new purge cassette into the controller. The system will automatically prime the purge cassette and tubing. Close controller door. Slide the purge cassette transmitter, flatside inward, into place and extend the purge tubing through the gap in door. 7. A blue bar shows the progress of the priming. When complete, you are prompted to connect the purge tubing to the Impella 5.0 or Impella LD Catheter. 8. Connect the yellow luer on the end of the purge tubing to the yellow luer on the Impella 5.0 or Impella LD Catheter. 9. Purge system change is complete. Enter the purge fluid values. a) To select the default purge fluid values: The controller will use the default values if no other selections are made. Turn the selector knob to select OK. Press the selector knob to confirm selection. The controller will advance to main operating screen b) To change the purge fluid values: Turn the selector knob to each individual value. Press the selector knob to open options. Scroll to desired value and press selector knob to confirm value. Continue procedure until all values are selected. Select OK by pressing selector knob. The controller will advance to main operating screen. Procedure Change Purge Fluid (Fluid only) 1. Press PURGE SYSTEM and turn the selector knob to select Change Purge Fluid from the menu. Press the selector knob to confirm selection. 2. Turn the selector knob to select OK and press selector knob to confirm a bolus to the pressure reservoir. A blue bar shows the progress of the bolus. When the bolus is delivered, the Controller advances to the next screen. 3. Clamp the purge tubing before removing the D5W bag/bottle. 4. Replace the D5W bag/bottle and unclamp the purge tubing. If the purge solution is supplied in bottles, open the vent on the purge tubing spike and proceed. 5. Press the selector knob to select OK to complete bag change. Purge system will begin operating. (continued) 36

49 6. Enter Purge Fluid Values To select default purge fluid values: Turn the selector knob to select OK. Press the selector knob to confirm selection. The controller will advance to the next screen. To change purge fluid values: Turn the selector knob to each individual value. Press the selector knob to open options. Scroll to the desired value and press selector knob to confirm value. Continue procedure until all values are selected. Select OK by pressing selector knob. The controller will advance to next screen. 7. Next screen provides option to flush fluid through the purge cassette. To flush cassette: Turn selector knob to select OK. (Proceed to Step 8 below.) To skip flush: Press EXIT. (Procedure complete.) The controller will use default values if no other selections are made. It may be helpful to flush fluid through the purge cassette when changing Dextrose concentration or Heparin concentration. 8. To flush fluid through the purge cassette: Turn the selector knob to select OK and press selector knob to confirm a bolus to the pressure reservoir. A blue bar shows the progress of the bolus. When the bolus is delivered, the controller advances to the next screen. Disconnect the yellow luer from the Impella 5.0 or Impella LD Catheter. Turn the selector knob to select OK. Press the selector knob to confirm flush. When flush is complete, connect the yellow luer to the Impella 5.0 or Impella LD Catheter (Or press BACK to repeat flush, then connect yellow luer). Procedure De-Air the Purge System Action Notes 1. Press PURGE SYSTEM and turn the selector knob to select De-air Purge System. Press selector knob to confirm selection. 2. Confirm that purge fluid bag/bottle is NOT empty or inverted and that tubing is NOT clamped. 3. Disconnect the yellow luer of the purge tubing from the Impella 5.0 or Impella LD Catheter. 4. Press OK to initiate the de-air function. Once complete, the controller advances to the next screen. 5. Confirm that no air remains in the purge tubing. If air remains, press BACK to repeat the air removal process. 6. Connect the yellow luer to the Impella 5.0 or Impella LD Catheter to complete the de-air procedure. (continued) 37

50 Procedure Change Purge Cassette Action Notes 1. Press PURGE SYSTEM and turn selector knob to select Change Purge Cassette from the menu. Press the selector knob to confirm selection. This procedure is only available if the Automated Impella Controller detects a defective purge cassette, purge pressure is low, or the purge system is open. 2. Open the new purge package. 3. Disconnect the yellow luer from the Impella 5.0 or Impella LD Catheter, then remove the used purge cassette from the controller. 4. Spike the D5W fluid bag/bottle If the purge solution is supplied in bottles, open the vent on the purge tubing spike and proceed. 5. Insert the new purge cassette into the controller. 6. The system will automatically prime the purge cassette. Once complete, you will be prompted to connect the yellow luer of the purge tubing to the Impella 5.0 or Impella LD Catheter. 7. Once the luer is connected, press OK to exit the procedure. Controller will advance to main operating screen. Follow-up Impella 5.0 or Impella LD Heart Pump Purge System change per hospital protocol. References (Supportive Data) Impella 5.0 or Impella LD Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 38

51 Transferring Impella 2.5 /Impella CP Supported Patient Transferring Impella 2.5 or Impella CP supported patient to care outside the cardiac cath lab The Impella 2.5 or Impella CP device product labeling acknowledges that situations may arise whereby a patient will need to be transferred from the cath lab to another location (either within the same hospital, or to another institution). Purpose To transfer patients supported with the Impella 2.5 or Impella CP catheter to care outside the cardiac cath lab Audience Healthcare providers transitioning patients from the cardiac cath lab to care outside the cardiac cath lab Desired Outcomes Maintain quality care for Impella 2.5 or Impella CP heart pump supported patients outside the cardiac cath lab Equipment StatLock stabilization device (optional) 0.9% NaCl infusion bag with pressure bag and provided standard IV infusion set (for transfer to standard configuration) Preparation Trained Transport Team in place Alerts Completely remove the peel-away introducer from the artery before peeling the wings. After 3 hours of operation, if you have not transferred to the standard configuration, the controller displays a message that it has automatically switched to P-level mode. The AUTO setting is no longer an option. Select OK to acknowledge. Procedure Preparation for Moving the Patient Action Notes 1. Verify correct Impella 2.5 or Impella CP Catheter position: Verify correct placement using echocardiography or fluoroscopy Remove any excess slack in the catheter to ensure that the catheter is laying along the lesser curve of the aorta 2. Identify a landmark on the red Impella 2.5 or Impella CP device plug and mark that location on the patient using a sterile marker or tape. You will use this landmark to help ensure correct Impella 2.5 or Impella CP Catheter positioning after removal of the repositioning sheath and peel-away introducer. 3. Flush the sidearm of the repositioning sheath and replace the cap. 4. Remove the 13 Fr or 14 Fr or peel-away introducer completely from the artery over the catheter shaft and apply manual pressure above the puncture site. (continued) 39

52 5. Grasp the two wings and bend back until the valve assembly comes apart. Continue to peel the two wings until the introducer is completely separated from the catheter shaft. 6. Slide the repositioning sheath over the catheter shaft and advance it into the artery to the blue hub. 7. Confirm that the landmark on the Impella 2.5 or Impella CP red plug is still aligned with the marking on the patient. 8. Secure the repositioning unit to the patient with the blue suture pads or a StatLock stabilization device. Be sure to tighten the Tuohy-Borst valve on the Impella 2.5 or Impella CP Catheter to prevent catheter migration. 9. Confirm dead-end cap is on the repositioning sidearm port. The sideport should not be used to give medication or draw blood due to possible clot formation. Pressure bags should not be connected to the sideport of the repositioning sheath. 10. Attach the anticontamination sleeve to the blue section of the repositioning sheath. Lock the anchoring ring in place by turning it clockwise. Secure the catheter shaft in place by tightening the connected anchoring ring. 11. Carefully extend the anticontamination sleeve to maximum length and secure the end closest to the red Impella 2.5 or Impella CP device plug by tightening the anchoring ring. 12. As soon as practical after catheter placement, change the purge fluid to include Heparin (D5W with 50 IU/mL Heparin recommended), if not already done. Follow the Change Purge Fluid procedure, which is described in the Impella 2.5 or Impella CP Device Purge System Management Procedures. (continued) 40

53 Procedure Transfer for Standard Configuration Upon transfer to the standard configuration, the controller will switch to P-level mode and operate at P-8 if previously running in AUTO. If the controller was already in P-level mode at the time of the transfer, it will continue operating at the P-level at which it was operating at the time of the transfer. Once the controller is operating in the standard configuration, AUTO is no longer an option on the flow menu. Action Notes 1. Press PURGE SYSTEM and turn the selector knob to select Transfer to Standard Configuration from the menu. Press the selector knob to confirm selection. Transition from the initial set-up configuration to the standard configuration (using the NaCl bag) as soon as practical. 2. Set up the sodium chloride (0.9% NaCl) infusion bag with pressure bag using straight tubing without injection ports or transducer. Pressurize bag to mmhg. 3. Clamp the red luer on the Y connector from the red pressure sidearm. Disconnect and end cap the red luer. 4. Create a slow drip from the NaCl pressure bag to flood the luer connector of the red pressure sidearm and make a wet-to-wet connection. Fully open the roller clamp. The controller may alarm during this step. 5. Turn the Selector Knob to select OK to confirm the transfer. Press the selector knob to confirm selection. You will no longer see the set-up icon on the bottom of the screen. The advisory alarm message will be gray. NOTE: When you transfer to the standard configuration, the purge pressure is no longer regulated at 600 mmhg. In standard configuration, purge flow can range from 2 30 ml/hr and purge pressure can range from mmhg. (continued) 41

54 Impella 2.5 / Impella CP ICU Check-in Create a Standard of Care around Impella 2.5 and Impella CP ICU Admission Assessments and Procedures Ensure every patient transferred to the ICU is settled in with proper positioning, purge system configuration, and volume status Minimize alarms and clinical issues with proactive management Call the Clinical Support Center (CSC) at or your local Abiomed representative to check-in every ICU admission to facilitate assistance with: Impella 2.5 or Impella CP ICU Admission Assessment Transfer to standard configuration if not done prior to transfer to ICU Proper positioning Impella 2.5 / Impella CP ICU Admissions Assessment 1. Complete an echo to verify Impella 2.5 or Impella CP Catheter position as soon as practical. Ensure the measurement from the Impella 2.5 or Impella CP device inlet to the annulus of the aortic valve is 3.5 cm. 2. Verify that the Tuohy-Borst valve on the Impella 2.5 or Impella CP Catheter is locked to prevent catheter migration. 3. Chart the centimeter marking on the Impella 2.5 or Impella CP Catheter closest to the sheath. 4. If the transfer to the standard configuration is not complete, follow the "Transfer to Standard Configuration" steps. 5. Ensure the roller clamp is completely open on the line to the NaCl pressure bag. 6. Verify that the pressure bag is inflated to mmhg. 7. Use a knee immobilizer if needed in accordance with hospital policy. 8. Secure the Impella 2.5 or Impella CP Catheter to the inner aspect of the patient's leg. 9. Chart urinary output and color. 10. Monitor CVP to optimize patient and support device management. Additional volume should be considered if any of the following are observed in the presence of CVP<10 or PCWP (PAD)<10, correct catheter placement, normal right ventricular function. Hemolysis as evidenced by hemoglobinuria or elevated plasma-free hemoglobin (PfHgb) levels. Suction alarms or evidence of motor current drops indicative of suction events. Inability to run at P-levels required for adequate support without suction alarms. Lower than expected flows for a given P-level. (continued) 42

55 Patient Transfer Call the Clinical Support Center (CSC) at or your local Abiomed representative: To inform Abiomed of patient transfer For assistance with preparing for transport For assistance with preparing to receive a patient on Impella 2.5 or Impella CP heart pump therapy Questions Dedicated and highly skilled Clinical Team available 24 hours a day, 7 days a week to provide: Technical Support Troubleshooting Clinical Support Device and Controller overview Best practice consulting Clinical Support Center phone system connects you directly to a Clinical Support Specialist, not an operator. (Call will route to an answering service if all consultant lines are busy.) Follow-up See Impella 2.5 or Impella CP Patient Care Procedures for post-implant care of Impella 2.5 or Impella CP heart pump supported patients. References (Supportive Data) Impella 2.5 or Impella CP Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 43

56 Transferring Impella 5.0 /Impella LD Supported Patient Transferring Impella 5.0 or Impella LD supported patient to care outside the operating room or cardiac cath lab The Impella 5.0 or Impella LD device product labeling acknowledges that situations may arise whereby a patient will need to be transferred to another location (either within the same hospital, or to another institution). Purpose To transfer patients supported with the Impella 5.0 or Impella LD catheter to care outside the operating room or cardiac cath lab Audience Healthcare providers transitioning patients from the operating room or cardiac cath lab to another care location Desired Outcomes Maintain quality care for Impella 5.0 or Impella LD heart pump supported patients outside the operating room or cardiac cath lab Equipment Fully charged Automated Impella Controller Preparation Trained Transport Team in place Alerts The Automated Impella Controller is designed to operate for 60 minutes on battery power. Transport teams should take this into consideration when planning a transport. If the total transport time is expected to include more than 60 minutes during which the system will be disconnected from AC power, make arrangements to use a vehicle with a built in DC to AC power inverter. The Transport Team should include person(s) fully trained in the use of the Automated Impella Controller, Impella 5.0 and Impella LD. Procedure Preparation and Transfer of the Patient Action Notes 1. Verify correct Impella 5.0 or Impella LD Catheter position: a) Verify correct position using echocardiography or fluoroscopy. b) Remove slack from Impella 5.0 catheter to ensure that the catheter is laying along the lesser curve of the aorta. 2. Flush the sidearm of the repositioning sheath, of the Impella 5.0 and cap. 3. Make sure there is no bleeding at the transition from the repositioning sheath, of the Impella 5.0 Catheter, to the femoral artery. Close and dress the wound. 4. Secure the repositioning unit by suturing it to the skin using the eyelet on the sheath. (continued) 44

57 5. Attach the anticontamination sleeve to the repositioning sheath. Lock it in place by turning it clockwise. 6. Tighten the Tuohy-Borst valve on the Impella 5.0 to prevent catheter migration. 7. The Impella Automated Controller should be fully charged prior to transport. The Automated Impella Controller, Impella 5.0 and Impella LD have been cleared by the FDA for Hospital-to-Hospital transport via ambulance, helicopter, or fixed-wing aircraft. 8. DO NOT stress the connector cable from the Controller to the Impella 5.0 /Impella LD Catheter. 9. Carefully monitor purge pressures during changes in altitude. 10. The Automated Impella Controller should be positioned to allow easy access to the display screen to view alarms and make any necessary changes. (continued) 45

58 Impella 5.0 / Impella LD ICU Check-in Create a Standard of Care around Impella 5.0 and Impella LD ICU Admission Assessments and Procedures Ensure every patient transferred to the ICU is settled in with proper positioning Minimize alarms and clinical issues with proactive management Call the Clinical Support Center (CSC) at or your local Abiomed representative to check-in every ICU admission to facilitate assistance with: Impella 5.0 or Impella LD ICU Admission Assessment Proper positioning Impella 5.0 / Impella LD ICU Admissions Assessment 1. Complete an echo, as soon as practical, to verify Impella 5.0 or Impella LD Catheter position. 2. Verify that the Tuohy-Borst valve on the Impella 5.0 Catheter is locked. 3. Chart the centimeter marking on the Impella 5.0 or Impella LD Catheter 4. Chart urinary output and color. 5. Monitor CVP to optimize patient support and device management. Additional volume should be considered if any of the following are observed in the presence of CVP <10 or PCWP (PAD) <10, correct catheter placement, normal right ventricular function. Hemolysis as evidenced by hemoglobinuria or elevated plasma-free hemoglobin (PfHgb) levels. Suction alarms or evidence of motor current drops, indicative of suction events. Inability to run at P-levels required for adequate support without suction alarms. Lower than expected flows for a given P-level. Patient Transfer Call the Clinical Support Center (CSC) at or your local Abiomed representative: To inform Abiomed Team of patient transfer For assistance with transport preparation For assistance with receiving a patient supported with Impella 5.0 /Impella LD therapy Clinical Support Center Dedicated and highly skilled clinical team available 24 hours/day to provide: Technical support Troubleshooting Clinical support Device and controller overview Best practice consulting Clinical Support Center phone system connects you directly to a clinical support specialist, not an operator (Call will route to an answering service if call specialist lines are busy). Follow-up See Impella 5.0 /Impella LD Patient Care Procedures for post-insertion care of the Impella 5.0 / Impella LD heart pump supported patients. References Impella 5.0 or Impella LD Catheter with Automated Impella Controller Instructions for User Manuals 46

59 Impella 2.5 /Impella CP Patient Care Procedures Purpose To care for a patient supported with the Impella 2.5 or Impella CP Catheter when unable to be weaned after Protected PCI procedures Audience Healthcare providers involved in the post-implant care of patients supported with the Impella 2.5 or Impella CP Catheter Desired Outcomes Equipment Preparation Alerts Orders Proper post-implant care for all patients supported with the Impella 2.5 or Impella CP Catheter Various hospital equipment; as described below Gather supplies prior to patient arrival The Impella 2.5 device has not been approved for > 6 hours of use, however, weaning could be delayed beyond the normal use for temporary support ( 6 hours), as an unintended consequence of a post procedure instability of the patient's hemodynamics. Should a physician decide to leave the Impella in place beyond 6 hours under the practice of medicine, he or she may wish to consider the following best practices: Patient care to be managed by attending cardiologist or cardiac surgeon, as per hospital policy Notify physician or Heart Team as appropriate of any changes in patient status and any Impella 2.5 or Impella CP Catheter or Automated Impella Controller issue Documentation Guidelines Action Notes 1. Initially and throughout Impella 2.5 / Impella CP heart pump support, assess and document: Hemodynamics (every 15 minutes for first hour, every 30 minutes for second hour, and then hourly when clinically stable) 2. Initiate Impella 2.5 or Impella CP heart pump support electronic or paper Flowsheet. Document parameters hourly during Impella 2.5 or Impella CP support. Parameter Expected values Notes Impella flow Motor current Purge flow rate Purge pressure Purge infusion volume Heparin dosing Purge D5W dose L/min (Impella 2.5 ) L/min (Impella CP ) Variable 2 30 ml/hr mmhg Variable; see Infusion History screen Variable; see Infusion History screen Variable; see Infusion History screen Flow rate can vary due to suction or incorrect positioning (continued) 47

60 3. Document ACT and Heparin dose In cardiac cath lab, maintain ACT at 250 seconds during Impella insertion and per procedural guidelines. Outside the cardiac cath lab, maintain ACT between seconds. 4. Document position of Impella 2.5 / Impella CP Catheter at insertion site using centimeter markings on the Impella 2.5 / Impella CP Catheter. 5. Document urine output and color. 6. Document vascular assessment, per hospital protocol Include ABI Pre-insertion (when available) Upon arrival to the ICU Doppler or palpable pulses During support and post removal 7. Document laboratory testing results per hospital protocol: PTT CBC Complete metabolic panel Plasma-free hemoglobin (PfHgb) Liver enzymes Reason for PfHgb: To evaluate for hemolysis. No need to duplicate tests found on other order sets. Orders Patient / Impella 2.5 or Impella CP Catheter Care Action Notes 1. Complete bed rest. 2. Head of bed at or below 30 degrees. 3. Moving the patient: a) Be careful not to pull on the Impella 2.5 or Impella CP Catheter when transferring a patient from one bed to another. b) Patient may be log-rolled. c) Do NOT torque chest or hips. Use care when moving the patient because the Impella 2.5 / Impella CP Catheter could move out of position and cause a positioning alarm. When log-rolling the patient, ensure you do not damage the infusion filter or pressure reservoir on the sidearm of the red Impella 2.5 or Impella CP device plug. (continued) 48

61 4. Immobilize affected leg; use knee immobilizer if needed, per hospital protocol. 5. Bladder catheter recommended for all patients unless contraindicated. 6. For the red placement monitoring sidearm on the Impella 2.5 or Impella CP device: Maintain pressure bag at mmhg. Change solution per hospital protocol. The red sidearm of the Impella 2.5 or Impella CP Catheter is used to flush the line of the placement signal. 7. Do NOT use or infuse any solution into the white sidearm of the repositioning unit of the Impella 2.5 or Impella CP Catheter. 8. To prevent kinking in the purge tubing: Do NOT allow the red Impella 2.5 or Impella CP device plug to hang freely from the catheter. Do NOT bend the catheter near the red Impella 2.5 or Impella CP device plug. May attach the red Impella 2.5 or Impella CP device plug and catheter to a short armboard to prevent kinking near the plug. 9. Dressing change: Sterile dressing change of femoral insertion site per hospital protocol and if dressing integrity becomes compromised or site appears wet. Use chlorhexidine (no ointment) and transparent non-gauze dressing. Use additional staff to stabilize catheter and monitor Impella 2.5 or Impella CP device position throughout dressing change. Do NOT clean the Impella 2.5 or Impella CP Catheter infusion filter or pressure reservoir with alcohol and AVOID exposing these components to products, such as skin preps and lotions, containing alcohol. Alcohol may cause cracks in the luer fitting connecting the clear sidearm components, resulting in leaking. (continued) 49

62 Orders Impella 2.5 or Impella CP Positioning Action Notes The distal tip of the Impella 2.5 or Impella CP Catheter must be in the left ventricle. When the catheter is positioned correctly, the placement signal waveform will be aortic and the motor current waveform will be pulsatile (similar to image on the right). If the distal tip of the Impella 2.5 or Impella CP Catheter becomes displaced: Reduce flow rate to P-2. Notify physician or Heart Team as appropriate. Obtain Echo STAT. (continued) 50

63 Orders Automated Impella Controller Action Notes Do NOT use the Automated Impella Controller placement signal for patient management. Use the arterial line or non-invasive cuff blood pressure. Maintain Impella 2.5 or Impella CP device flow to achieve target hemodynamics. Do NOT reduce flow below P-2. Assure that patient has adequate supply of purge cassettes for purge system changes before cardiac cath lab closes for the evening or weekend. P-Levels below P-2 may result in retrograde flow. Refer to Impella 2.5 or Impella CP device Purge System Management Procedures. Automated Impella Controller management: Have back-up controller plugged in close to patient room Controller will operate on battery power for 60 minutes if batteries are fully charged Press and hold the power switch for 30 seconds for Emergency Shut Down, if necessary Procedure Impella 2.5 /CP Chest Compressions and Defibrillation Action Notes 1. Chest compression and defibrillation may be administered during Impella 2.5 or Impella CP support when necessary. 2. Impella 2.5 or Impella CP Catheter or Controller do not need to be turned off (stopped at P-0) or unplugged to defibrillate the patient. 3. Reduce P-Level to P-2 prior to and during chest compressions. 4. When cardiac function has been restored, assess Impella 2.5 or Impella CP Catheter position using placement signal waveform on Controller or Echo, then return to previous P-Level. Follow-up Abiomed 24-hour Clinical Support Center (CSC): References (Supportive Data) Impella 2.5 and Impella CP Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 51

64 Impella 5.0 /Impella LD Patient Care Procedures Purpose Audience Desired Outcomes Equipment Preparation Alerts Orders To care for a patient supported with the Impella 5.0 or Impella LD Catheter when unable to be weaned after Protected PCI procedures Healthcare providers providing post-implant care of patients supported with the Impella 5.0 or Impella LD Catheter Proper post-op care for all patients supported with the Impella 5.0 or Impella LD Catheter Various hospital equipment; as described below Gather supplies prior to patient arrival Patient care to be managed by attending cardiologist or cardiac surgeon, per hospital policy Notify physician or Heart Team as appropriate of any changes in patient status and any Impella 5.0 or Impella LD Catheter or Automated Impella Controller issue Documentation Guidelines Action Notes 1. Initially and throughout Impella 5.0 or Impella LD heart pump support, assess and document: Hemodynamics (every 15 minutes for first hour, every 30 minutes for second hour, and then hourly when clinically stable) 2. Initiate Impella 5.0 or Impella LD heart pump support electronic or paper Flow Sheet. Document parameters hourly during Impella 5.0 or Impella LD support. Parameter Expected values Notes Impella flow Motor current Purge flow rate Purge pressure Purge infusion volume Heparin dosing Purge D5W dose L/min (Impella 5.0 ) L/min (Impella LD ) Variable 2 30 ml/hr mmhg Variable; see Infusion History screen Variable; see Infusion History screen Variable; see Infusion History screen Flow rate can vary due to suction or incorrect positioning. (continued) 52

65 3. Document ACT and Heparin dose a) During insertion, maintain ACT at 250 seconds and per procedural guidelines. b) Post-implant, maintain ACT between seconds. 4. Document position of Impella 5.0 or Impella LD at femoral, axillary, or direct insertion site using catheter centimeter markings. 5. Document urine output and color. 6. Document vascular assessment, per hospital protocol, distal to insertion site a) Include ABI b) Pre-insertion (when available) c) Upon arrival to the ICU d) During support and post removal 7. Document laboratory testing results per hospital protocol: a) PTT b) CBC c) Complete metabolic panel d) Plasma-free hemoglobin (PfHgb) e) Liver enzymes Reason for PfHgb: To evaluate for hemolysis. No need to duplicate tests found on other order sets. Orders Patient/Impella 5.0 or Impella LD Care Action Notes 1. Complete bed rest with Impella 5.0 femoral artery insertion. 2. Head of bed at or below 30 degrees for Impella 5.0 femoral artery insertion. 3. Moving the patient: a) Be careful not to pull on the Impella 5.0 or Impella LD Catheter when transferring a patient from one bed to another. b) Patient may be log-rolled. c) Do NOT torque chest, hips, or arm. (continued) 53

66 4. For femoral artery insertion, immobilize affected leg using knee immobilizer. Use per hospital protocol. 5. Bladder catheter recommended for bed rest patients unless contraindicated. 6. DO NOT use or infuse any solution into the white sidearm of the repositioning sheath of the Impella 5.0 Catheter. 7. To prevent kinking in the purge tubing: DO NOT allow the red Impella 5.0 or Impella LD device plug to hang freely from the catheter. DO NOT bend the catheter near the red plug. May attach the red plug of the Impella 5.0 or Impella LD Catheter to a short arm board to prevent kinking. 8. Dressing change: Sterile dressing change of insertion site per hospital protocol and if dressing integrity becomes compromised or site appears wet. Use chlorhexidine (no ointment) and transparent non-gauze dressing. May use additional staff to stabilize catheter and monitor position during dressing change. DO NOT clean the Impella 5.0 or Impella LD Catheter infusion filter or pressure reservoir with alcohol and AVOID exposing these components to products, such as skin preps and lotions, containing alcohol. Alcohol may cause cracks in the luer fitting, resulting in leaking. (continued) 54

67 Orders Impella 5.0 or Impella LD Positioning Action Notes The distal tip of the Impella 5.0 or Impella LD must be in the left ventricle. When positioned correctly, the placement signal (Differential Pressure) and Motor Current Waveform will be pulsatile If the distal tip of the Impella 5.0 or Impella LD Catheter becomes displaced: Reduce P-Level to P-2 Notify physician or Heart Team as appropriate STAT Obtain Echo STAT Orders Automated Impella Controller Maintain Impella 5.0 or Impella LD device flow to achieve target hemodynamics. Do not reduce P-Level to level below P-2. Assure that patient has adequate supply of purge cassettes for purge system changes. P-Levels below P-2 may result in retrograde flow. Refer to Impella 5.0 or Impella LD device purge system management procedures Automated Impella Controller management: Have back-up controller plugged in close to patient room Controller will operate on battery power for 60 minutes if batteries are fully charged Press and hold the power switch for 30 seconds for Emergency Shut Down, if necessary Procedure Impella 5.0 /Impella LD Chest Compressions and Defibrillation Action Notes 1. Chest compression and defibrillation may be administered during Impella 5.0 or Impella LD support when necessary. 2. Impella 5.0 or Impella LD Catheter or Controller do not need to be turned off (stopped at P-0) or unplugged to defibrillate the patient. 3. Reduce P-Level to P-2 prior to and during chest compressions. 4. When cardiac function has been restored, assess Impella 5.0 or Impella LD Catheter position using placement signal waveform on Controller or Echo, then return to previous P-Level. Follow-up Abiomed 24-hour Clinical Support Center (CSC): References (Supportive Data) Impella 5.0 or Impella LD Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 55

68 Impella 2.5 /Impella CP Catheter Weaning Procedures NOTE: The Impella 2.5 Catheter is approved for use for periods of up to 6 hours in patients undergoing Protected PCI. The Impella 2.5 and Impella CP Catheters, in conjunction with the Automated Impella Controller, are indicated for use for periods of up to 4 days in the treatment of ongoing cardiogenic shock. However, the Instructions for Use manuals recognize that the devices might be used for longer durations at the discretion of the physician due to unforeseen circumstances. Purpose To wean Impella 2.5 /Impella CP supported patient in preparation for Impella Catheter removal Audience Healthcare providers involved in weaning procedure for Impella 2.5 /Impella CP Catheter Desired Outcomes Patient will remain hemodynamically stable throughout weaning procedure Equipment Equipment in place Preparation Multidisciplinary decision to proceed with weaning procedure Alerts The following weaning instructions are provided as guidance only Procedure Rapid Weaning Action Notes 1. To initiate rapid weaning, press FLOW CONTROL. Turn selector knob to reduce P-level by 2-level increments over time intervals as cardiac function allows. Press selector knob to confirm selections. 2. Maintain Impella Catheter P-level at P-2 or above until the catheter is ready to be removed from the left ventricle. 3. If the patient's hemodynamics remain stable, reduce the P-level to P-1 and pull the Impella 2.5 /Impella CP Catheter across the aortic valve into the aorta. 4. If the patient's hemodynamics continue to remain stable, follow instructions for removing the Impella 2.5 /Impella CP Catheter. Follow-up Remove Impella 2.5 /Impella CP Catheter after weaning successfully completed. References Impella 2.5 or Impella CP Catheter with Automated Impella Controller Instructions for Use Manuals 56

69 Impella 5.0 /Impella LD Catheter Weaning Procedures NOTE: The Impella 5.0 and Impella LD Catheters, in conjunction with the Automated Impella Controller, are indicated for use for periods of up to 6 days in the treatment of ongoing cardiogenic shock. However, the Instructions for Use manuals recognize that the devices might be used for longer durations at the discretion of the physician due to unforeseen circumstances. Purpose To wean patient from Impella 5.0 /Impella LD supported patient in preparation for Impella Catheter removal Audience Healthcare providers involved in weaning procedure for Impella 5.0 /LD Catheter Desired Outcomes Patient will remain hemodynamically stable throughout weaning procedure Equipment Equipment in place Preparation Multidisciplinary decision to proceed with weaning procedure Alerts The following weaning instructions are provided as guidance only Procedure Rapid Weaning Action Notes 1. To initiate weaning, press FLOW CONTROL. Turn selector knob to reduce P-level by 2-level increments over time intervals as cardiac function allows. Press selector knob to confirm selections. DO NOT decrease P-Level to below P-2 until just before removing catheter from ventricle. 2. When the P-Level has been reduced to P-2, maintain the patient on P-2 for at least 10 minutes before discontinuing Impella 5.0 /LD support. 3. If the patient's hemodynamics remain stable, reduce the P-level to P-1 and pull the Impella 5.0 /LD Catheter across the aortic valve into the aorta. 4. If the patient's hemodynamics continue to remain stable, follow instructions for removing the Impella 5.0 /LD Catheter. Refer to the Impella 5.0 or Impella LD Catheter Explant Procedure. Procedure Slow Weaning Action Notes 1. To initiate slow weaning, press FLOW CONTROL. Turn selector knob to reduce P-Level by 1-2 level increments over slow time intervals as cardiac function allows. Press selector knob to confirm selections. Weaning P-Level example: P-8 to P-7 to P-6 to P-5 to P-4 to P-3 to P-2. (continued) 57

70 2. When the P-Level has been reduced to P-2, maintain the patient on P-2 until the patient's hemodynamics remain stable. 3. If the patient's hemodynamics remain stable, reduce P-Level to P-1 and pull Impella 5.0 /LD Catheter across the aortic valve into the aorta. 4. If the patient's hemodynamics remain stable, follow instructions for removing the Impella 5.0 /Impella LD Catheter. Follow-up Remove Impella 5.0 /Impella LD Catheter after weaning successfully completed. References (Supportive Data) Impella 5.0 or Impella LD Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 58

71 Impella 2.5 /Impella CP Catheter Explant Procedures Purpose To explant the Impella 2.5 or Impella CP Catheter Audience Healthcare providers involved in explanting the Impella 2.5 or Impella CP Catheter Desired Outcomes Patient maintains adequate hemodynamics Equipment None for manual compression Compression assist devices (optional) Preparation Patient must be weaned to P-Level of P-2 prior to explanting the Impella 2.5 or Impella CP Catheter. (Refer to the Impella 2.5 or Impella CP Catheter Weaning Procedure.) Alerts Control bleeding at arteriotomy site during the explant procedure Procedure Removing the Impella 2.5 or Impella CP Catheter with the Introducer in Place Action Notes 1. Wean the patient by following the Weaning Procedure. 2. Pull Impella catheter across Aortic Valve at P-Level of P-1. The controller will alarm. 3. Once the Impella 2.5 or Impella CP device is out of the left ventricle, reduce the P-level to P Remove the Impella 2.5 or Impella CP Catheter through the introducer. 5. Wait until ACT drops below 150 seconds. 6. When ACT is below 150 seconds, remove the introducer. 7. Disconnect the connector cable from the Automated Impella Controller and turn the controller off. Press the black power switch on the right side of the Automated Impella Controller for 3 seconds to turn the controller off. 8. Apply direct pressure with fingers positioned over and proximal to the arteriotomy site, while maintaining a faint distal pulse. Duration: 40 minutes or per hospital protocol. Maintain consistent pressure as inconsistent pressure can lead to formation of hematoma. For patients requiring prolonged pressure, a mechanical compression device can be used per hospital protocol. (continued) 59

72 Procedure Removing the Impella 2.5 or Impella CP /CP Secured with the Repositioning Sheath Action Notes 1. Wean the patient by following Weaning Procedure. 2. Leave the Impella 2.5 or Impella CP Catheter in the ventricle at a P-level of P-2 until ACT drops below 150 seconds or reduce the P-level to P-2, pull the Impella 2.5 or Impella CP Catheter into the aorta (approximately 30 to 40 cm), and wait until the ACT drops below 150 seconds. 3. When the ACT is below 150 seconds, reduce the P-level to P-0. The Impella Catheter will NOT come through the repositioning sheath. 4. Remove the Impella Catheter and repositioning sheath together. 5. Disconnect the connector cable from the Automated Impella Controller and turn the controller off. Press the black power switch on the right side of the Automated Impella Controller for 3 seconds to turn the controller off. 6. Apply manual compression for 40 minutes or per hospital protocol. Maintain consistent pressure as inconsistent pressure can lead to formation of hematoma. For patients requiring prolonged pressure, a mechanical compression device can be used per hospital protocol. Follow-up Per hospital protocol. References (Supportive Data) Impella 2.5 or Impella CP Catheter with Automated Impella Controller Instructions for Use Manuals Approval Effective Date Revision Date(s) 60

73 Impella 5.0 Catheter Explant Procedure Purpose To explant the Impella 5.0 Catheter Audience Healthcare providers involved in explanting the Impella 5.0 Catheter Desired Outcomes Patient maintains adequate hemodynamics Equipment Institutional supplies for explant via femoral or axillary artery and graft closure procedure (Impella 5.0 ) Preparation Transport patient to Operating Room suite Patient must be weaned to P-Level of P-2 prior to explanting the Impella 5.0 Catheter Alerts The Impella 5.0 Catheter should only be removed when the P-Level is set to P-0 Perform the following steps under fluoroscopy guidance Procedure Removing The Impella 5.0 Catheter Action Notes 1. Gain exposure and clear access to the femoral or axillary artery insertion site. 2. If the patient's hemodynamics remain stable, decrease the P-Level to P Pull the Impella 5.0 Catheter across the aortic valve into the aorta. 4. Stop the motor by decreasing the P-Level to P Explant the Impella 5.0 Catheter. Removal of the Impella 5.0 Catheter must be completed with care to avoid damage to the Catheter assembly. 6. Follow institutional guidelines for femoral artery closure or axillary graft closure. 7. Disconnect the connector cable from the Automated Impella Controller by pressing the black power switch on the right side for 3 seconds. 61

74 Impella LD Catheter Explant Procedure Purpose Audience Desired Outcomes Equipment To explant the Impella LD Catheter Healthcare providers involved in explanting the Impella LD Catheter Patient maintains adequate hemodynamics Institutional supplies for explant via ascending aortic graft and graft closure procedure Preparation Transport patient to Operating Room suite Patient must be weaned to P-Level of P-2 prior to explanting the Impella LD Catheter Alerts The Impella LD Catheter should only be removed when the P-Level is set to P-0 Perform the following steps under Transesophageal Echocardiography (TEE) guidance Procedure Removing the Impella LD Catheter Action Notes 1. Gain exposure and clear access to the ascending aorta insertion site, the Dacron vascular graft, and the sites at which the silicone plugs are secured to the graft. 2. Undo the penetrating suture from the front silicone plug and remove the suture entirely. 3. Remove the ligature from the rear silicone plug and remove the plug from the end of the vascular graft. 4. Maintaining distal control digitally, remove the final circumferential ligature from the front silicone plug. 5. Allow controlled bleed-back through the graft to clear any residual thrombus fromthe lumen of the graft. 6. Immediately reduce the P-Level to P Carefully pull the Impella LD Catheter back through the aortic valve and into the ascending aorta. Depending on the level of the insertion site, a portion of the catheter may be pulled through the aortotomy and into the vascular graft. 8. Immediately reduce the P-Level to P Gently pull the Impella LD Catheter through the aortotomy and into the vascular graft. 10. Explant the Impella LD Catheter. 11. Close the vascular graft. 12. Disconnect the connector cable from the Automated Impella Controller and turn Controller off by pressing the black power switch on the right side for 3 seconds. 62

75 63

76 Impella Program Implementation Tools Impella 2.5 /Impella CP Catheter Certification Process for Physicians Impella 5.0 /Impella LD Catheter Certification Process for Physicians Impella 2.5 /Impella CP Catheter Certification Process for Advanced Cardiac Cath Lab and ICU Users Impella 5.0 /Impella LD Catheter Certification Process for Advanced Cardiac Cath Lab and ICU Users Impella 2.5 /Impella CP Cardiac Cath Lab Tech Skills Checklist Impella 2.5 /Impella CP Cardiac Cath Lab Circulator Skills Checklist Impella 5.0 /Impella LD Operating Room Scrub Skills Checklist Impella 5.0 /Impella LD Circulator/Perfusionist Skills Checklist Transfer of Care Impella 2.5 /Impella CP Skills Checklist (peel-away sheath) Transfer of Care Impella 2.5 /Impella CP Skills Checklist (non-peel-away sheath) Impella 2.5 /Impella CP Supply List Impella 5.0 /Impella LD Supply List 64

77 Impella Certification Process for Physicians Purpose Hospital credentialing for Impella device placement Audience Physicians who implant Impella devices Desired Outcomes Physicians will be certified to implant Impella devices Equipment N/A Preparation N/A Alerts N/A Process REQUIREMENTS FOR IMPELLA CERTIFICATION Requirements Additional information 1. Participate in ONE of the following Abiomed Protected PCI with Impella Programs: a) Attend device appropriate on-site didactic training with course slides OR On-site training requires documented participation by physician and Abiomed representative. Completion of online Protected PCI with Impella Program requires review of all materials and passing online exam. b) Complete relevant online Protected PCI with Impella Program at 2. Perform at least TWO successful Impella device implants and explants in the presence of an Abiomed representative. Abiomed representative must proctor a physician on site for a minimum of TWO live cases and complete, sign, and submit the Physician Certification Request and Sign-Off form to Abiomed. 3. Sign Physician Certification Request and Sign-Off form after completing Impella device cases with Abiomed representative. Abiomed representative will provide the form for the physician; physician will receive certificate of Impella Certification from Abiomed representative after the completed form is submitted and the certificate has been processed. Follow-up N/A References (Supportive Data) Adapted from Physician Certification Process and Requirements for Impella, Abiomed, Inc., Danvers, MA Approval Effective Date Revision Date(s) 65

78 Impella Certification Process for Advanced Users Purpose Audience Desired Outcomes Equipment Preparation Alerts Process To fulfill hospital requirement for competency and independence in the use of Impella technology. Cardiac cath lab personnel and ICU/CCU nurses Cardiac cath lab personnel and ICU/CCU nurses will be certified in use of Impella devices N/A N/A N/A Requirements for Impella Certification Requirements 1. Complete relevant online Impella Protected PCI with Impella Program at 2. Complete device appropriate on-site 1:1 didactic training with Abiomed representative using course slides AND participate in hands-on product training with Abiomed representative. 3. Complete ONE of the following: a) Serve as the cardiac cath lab point person for at least TWO successful Impella device implants and explants in the presence of an Abiomed representative. OR b) Serve as the lead ICU/CCU nurse for at least TWO Impella heart pump supported patients in the presence of an Abiomed representative. 4. Sign Advanced User Certification Request and Sign-Off form after completing Impella device cases with Abiomed representative. Additional information Completion of online Protected PCI with Impella Program requires review of all materials and passing online exam. On-site training requires documented participation by advanced user and Abiomed representative. Cath lab point person must assume primary responsibility for the set-up and operation of the controller during each Impella device case. Lead ICU/CCU nurse must assume primary responsibility for the postimplant support of the patient and controller for each Impella device case. Abiomed representative will provide the form; The advanced user will receive certificate of Impella Certification from Abiomed representative after the completed form is submitted and the certificate has been processed. Follow-up References (Supportive Data) N/A Adapted from Advanced User Certification Process for Impella, Abiomed, Inc., Danvers, MA Approval Effective Date Revision Date(s) 66

79 67

80 Impella 2.5 or Impella CP Tech Skills Name: Date: Trainer: Objective Successful Unsuccessful Comments 1. Gathers and describes correct supplies for procedure. 2. Can correctly describe physician steps for vascular access. 3. States correct ACT required before removing dilator. 4. Demonstrates ability to open purge cassette and hand-off of spike and cassette to circulator. 5. Correctly demonstrates removal of end caps on yellow and red luers. 6. Correctly demonstrates tightening of solid yellow connectors at filter. 7. Correctly demonstrates opening white connector cable; hands off round, white controller end to circulator. 8. Correctly opens Impella Catheter (after vascular access is established) and plugs in white connector cable. 9. Correctly connects luers red to red, yellow to yellow. 10. Pinches and holds white wings on placement signal/red side arm as controller instructs. 11. Can correctly identify when catheter is ready to insert. 12. Correctly describes backloading the Impella 2.5 / Impella CP Catheter over the wire through the RED Easy Guide Lumen. 13. Correctly describes removing the Easy Guide lumen. 14. Correctly describes advancing Impella 2.5 / Impella CP Catheter through the 13/14 Fr sheath to the correct location. 15. Correctly describes removing wire before instructing circulator to start Impella 2.5 / Impella CP Flow. 16. Able to describe correct position of catheter. 68

81 Impella 2.5 or Impella CP Circulator Skills Name: Date: Trainer: Objective Successful Unsuccessful Comments 1. Gathers and describes supplies for procedure. 2. Correctly demonstrates how to turn on Automated Impella Controller. 3. Hands-up purge cassette to sterile field and correctly inserts purge cassette and positions transducer. 4. Instructs to remove red and yellow end caps on luers and tighten solid yellow connector at filter. 5. Correctly demonstrates hand-off of round, white connector cable to tech and connects to Impella controller. 6. Once vascular access is confirmed, hands-up Impella 2.5 / Impella CP Catheter to sterile field. 7. Instructs tech to connect luers yellow to yellow, red to red. 8. Instructs tech to pinch and hold white wings on placement signal red sidearm as controller instructs. 9. Can correctly identify when catheter is ready to insert. 10. Inputs correct values for purge solution. 11. Ensures wire is removed before starting Impella 2.5 / Impella CP Flow. 12. Verifies correct placement notes that motor current should be pulsatile. 13. Document cm markings on Impella 2.5 / Impella CP Catheter at sheath (prior to transfer). 14. Appropriately documents procedure and flows. 15. Demonstrates weaning and Automated Impella Controller shutdown. 69

82 Impella 5.0 and Impella LD Scrub Skills Name: Date: Trainer: Objective Successful Unsuccessful Comments 1. Describes correct supplies needed of peripheral, axillary and direct insertion. 2. Correctly describes physician steps to gain insertion access. 3. States required ACT for insertion of Catheter. 4. Correctly opens Impella Catheter in sterile field. 5. Correctly demonstrates ability to open purge cassette and hand-off of spike and cassette to Circulator. 6. Correctly demonstrates hand-off of round, white end of connector cable. 7. Can correctly identify when catheter is ready to insert. 8. Correctly describes steps to peripheral, axillary, and direct approach. 9. Correctly describes when Impella Catheter can be turned on. 70

83 Impella 5.0 and Impella LD Circulator or Perfusionist Skills Name: Date: Trainer: Objective Successful Unsuccessful Comments 1. Describes correct supplies needed for peripheral, axillary, and direct insertion. 2. Correctly describes physician steps to gain insertion access 3. States required ACT for insertion of Catheter. 4. Correctly passes Catheter into sterile field. 5. Correctly demonstrates connecting purge system to Automated Impella Controller. 6. Correctly demonstrates inserting connector cable into controller. 7. Correctly demonstrates steps to prime purge system and Catheter. 8. Can correctly describe when Catheter is ready to insert. 9. Describes correct position of Impella 5.0 and Impella LD Catheter. 10. Correctly describes P-Level and how to change levels. 11. Correctly troubleshoots alarms. 71

84 Transfer of Care Impella 2.5 /Impella CP Skills Checklist (peel-away sheath) Name: Date: Trainer: The employee can successfully demonstrate the following: Lab to ICU Set Up Procedure When 13 or 14 Fr Peel-away sheath is present Objective Successful Unsuccessful Comments 1. State type of sheath in place. 2. Correctly explain separation of repositioning sheath from anticontamination sleeve. 3. Demonstrates flushing of repositioning sheath. 4. Correctly explains removal of peel-away sheath from artery, cracking hub, and peeling sheath (including pressure assistance). 5. Correctly explains process of advancing sheath into artery. 6. Correctly adjusts Impella flow. 7. Correctly explains need for slack removal and verifying catheter position. 8. Verifies catheter placement on placement signal and motor current. 9. Can state correct distance from aortic valve annulus (3.5 cm). 10. Advances anticontamination sleeve and connects to repositioning sheath. 11. Appropriately secures repositioning sheath. 12. Tightens Tuohy-Borst valve and documents CM marker on catheter. 13. Applies knee brace or hospital appropriate device to support placement. 72

85 Transfer of Care Impella 2.5 /Impella CP Skills Checklist (non-peel-away sheath) Name: Date: Trainer: The employee can successfully demonstrate the following: Lab to ICU Set Up Procedure When 14 Fr Non-peel-away sheath is used Objective Successful Unsuccessful Comments 1. State type of sheath in place. 2. Correctly explains process of advancing distal segment of reposition sheath into the hub of the 13 Fr - 14 Fr sheath. 3. Correctly describes adjusting Impella flow. 4. Correctly explains need for slack removal and verifying catheter position. 5. Verifies catheter placement on placement signal and motor current. 6. Can state correct distance from aortic valve annulus (3.5 cm). 7. Advances anticontamination sleeve and connects to repositioning sheath. 8. Appropriately secures repositioning sheath. 9. Tightens Tuohy-Borst valve and documents CM marker on catheter. 10. Applies knee brace or hospital appropriate device to support placement. 11. Ensures pressure bag is applied to side arm of cook sheath at >300 mmhg. 73

86 Impella 2.5 or Impella CP ICU RN Skills Name: Date: Trainer: Objective Successful Unsuccessful Comments 1. Correctly states need for AC power and states length of battery live for Automated Impella Controller. 2. Correctly describes correct catheter position on ECHO, Placement Signal screen, Motor Current screen, cm markings. 3. Describes appropriate use of knee immobilizer. 4. Demonstrates proper use of NaCl on pressure bag. 5. Correctly describes P-Level and associated Flow. 6. Correctly describes use of Impella Purge System with Dextrose concentration and Heparin concentration. 7. Correctly demonstrates Purge System changes per ICU protocol. 8. Correctly describes ICU protocol for troubleshooting alarms. 9. Correctly states use of Abiomed Clinical Support Center. 74

87 Impella 5.0 or Impella LD ICU RN Skills Name: Date: Trainer: Objective Successful Unsuccessful Comments 1. Correctly describes implant site options for Impella 5.0 Catheter, implant site for Impella LD. 2. Correctly describes correct catheter position on ECHO, Placement Signal screen, Motor Current screen, cm markings. 3. Correctly describes P-Level and associated Flow. 4. Correctly describes use of Impella Purge System with Dextrose concentration and Heparin concentration. 5. Correctly demonstrates Purge System changes per ICU protocol. 6. Correctly describes ICU protocol for troubleshooting alarms. 7. Correctly describes transport of patient to operating room for procedures. 8. Correctly states use of Abiomed Clinical Support Center. 75

88 Impella 2.5 /Impella CP Supply List Impella 2.5 /Impella CP Insertion Kit Contains: Impella Catheter 0.018" x 260 cm placement guidewire White connector cable Purge cassette IV infusion set Introducer Kit Peel-away introducer (13 Fr Impella 2.5, 14 Fr Impella CP ) 18 G Seldinger needle (Impella 2.5) 12 ml syringe (Impella 2.5) 0.035" stiff access wire 8 Fr, 10 Fr, 12 Fr, 14 Fr dilators (Impella CP ) Hospital supplied items: Automated Impella Controller 500 ml bag of D5W (5% recommended; 5% - 40% acceptable) with Heparin 50 IU/mL (recommended) 5-8 Fr Introducer 8 Fr, 10 Fr, 12 Fr dilators 6 Fr MP, AL-1 diagnostic catheter without side holes OR 5 Fr; pigtail with or without side holes Standard x 180 cm J-Tip Guidewire Case savers/extra items: 14 Fr x 13 cm Cook Check-Flo Introducer (Impella 2.5 only) 14 Fr x 30 cm Cook Check-Flo Performer Introducer (non-peel-away) Boston Scientific Platinum Plus, 0.018" guidewire Boston Scientific V-18 Control Wire 0.018" guidewire Supplies for Transfer to Standard Configuration 500 ml bag of NaCl with pressure bag IV infusion set without transducer (90" recommended) 500 ml bag of D5W (5% recommended, 5% - 40% acceptable) with Heparin 50 IU/mL (recommended) Back-up purge cassette 76

89 Impella 5.0 /Impella LD Supply List Impella 5.0 /Impella LD Insertion Kit Contains: Impella Catheter 0.018" x 260 cm placement guidewire White connector cable Purge cassette Impella Axillary Insertion Kit 23 Fr x 6 cm peel-away introducer 2 Graft locks 8 Fr silicone-coated lubrication dilator 2 Silicone plugs Impella LD Insertion Kit Impella Catheter White connector cable Purge cassette Incision template Hospital supplied items: Automated Impella Controller 500 ml bag of D5W (5% recommended; 5% - 40% acceptable) with Heparin 50 IU/mL (recommended) 10 mm x 20 cm vascular graft (Impella 5.0 ) 10 mm x 15 cm vascular graft (Impella LD ) 6 Fr MP, AL-1 diagnostic catheter without side holes OR 5 Fr. Pigtail with or without side holes (Impella 5.0 ) Standard x 180 cm J-Tip Guidewire (Impella 5.0 ) 77

90 Appendix A: Program Resources Patient Education and Outreach Program Patient Education Abiomed has resources available to assist in education of patients and family members. Please visit our website at Outreach Education Abiomed has resources available to assist outreach education. Please visit our website at for more information on outreach education. Additional Staff Training Resources Impella Quick Skills Mobile by Abiomed, Inc., puts key Impella information at your fingertips. Instantly review set-up and insertion videos and instructions by downloading the Impella App from the itunes or GooglePlay directly to your smartphone or tablet. Download The IMPELLA APP Today 78

Cardiogenic Shock Protocol

Cardiogenic Shock Protocol Cardiogenic Shock Protocol Impella Devices Best Practices in AMI Cardiogenic Shock Identify 1-3 SBP < 90 mmhg or on inotropes /pressors Cold, clammy, tachycardia Lactate elevated > 2 mmoi /L Stabilize

More information

A National Cardiogenic Shock Initiative (CSI):

A National Cardiogenic Shock Initiative (CSI): A National Cardiogenic Shock Initiative (CSI): Insights from the Impella Quality (IQ) Program, cvad Registry and the Detroit CSI Experience William O Neill, MD, FACC Medical Director Structural Heart Disease

More information

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California High Risk PCI Making Possible the Impossible Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California Disclosures Abiomed Research Support Consulting Agreement

More information

COURSE OFFERINGS. Committed to Improving Outcomes in Cardiogenic Shock and Protected PCI Through Excellence in Education.

COURSE OFFERINGS. Committed to Improving Outcomes in Cardiogenic Shock and Protected PCI Through Excellence in Education. 2017 COURSE OFFERINGS Committed to Improving Outcomes in Cardiogenic Shock and Protected PCI Through Excellence in Education. ABOUT THIS COURSE BOOKLET Abiomed offers a full curriculum of educational programs

More information

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4 1 TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA FDA APPROVES IMPELLA FOR HIGH-RISK PCI 2 Impella is the only hemodynamic support device proven safe and effective in elective

More information

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize

The Role of Mechanical Circulatory Support in Cardiogenic Shock: When to Utilize The Role of Mechanical Circulatory Support in Cardiogenic Shock: Presented by Nancy Scroggins ACNP, CNS-CC CV Surgery ACNP Bayshore Medical Center The Role of Mechanical Circulatory Support in Cardiogenic

More information

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO)

Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO) Cath Lab Essentials : LV Assist Devices for Hemodynamic Support (IABP, Impella, Tandem Heart, ECMO) Michael A. Gibson, MD Assistant Professor of Medicine University of California, Irvine Division of Cardiology

More information

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER

1 Description. 2 Indications. 3 Warnings ASPIRATION CATHETER Page 1 of 5 ASPIRATION CATHETER Carefully read all instructions prior to use, observe all warnings and precautions noted throughout these instructions. Failure to do so may result in complications. STERILE.

More information

Recovering Hearts. Saving Lives.

Recovering Hearts. Saving Lives. Recovering Hearts. Saving Lives ṬM The Door to Unload (DTU) STEMI Safety & Feasibility Pilot Trial November 218 Recovering Hearts. Saving Lives. LEGAL DISCLAIMERS This presentation includes select slides

More information

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist

Management of Cardiogenic Shock. Dr Stephen Pettit, Consultant Cardiologist Dr Stephen Pettit, Consultant Cardiologist Cardiogenic shock Management of Cardiogenic Shock Outline Definition, INTERMACS classification Medical management of cardiogenic shock PA catheters and haemodynamic

More information

Percutaneous Mechanical Circulatory Support Devices

Percutaneous Mechanical Circulatory Support Devices Percutaneous Mechanical Circulatory Support Devices Daniel Vazquez RN, RCIS Miami Cardiac & Vascular Institute FINANCIAL DISCLOSURES none CASE STUDY CASE STUDY 52 year old gentlemen Complaining of dyspnea

More information

Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support

Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support Recognizing the Need to Support A Failing Right Ventricular Role of Mechanical Support Mahir Elder, MD, FACC,SCAI Medical Direct of PERT program Medical Director of Endovascular medicine Clinical Professor

More information

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Rationale for Prophylactic Support During Percutaneous Coronary Intervention Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories

More information

Management of Acute Shock and Right Ventricular Failure

Management of Acute Shock and Right Ventricular Failure Management of Acute Shock and Right Ventricular Failure Nader Moazami, MD Department of Thoracic and Cardiovascular Surgery and Biomedical Engineering, Cleveland Clinic NONE Disclosures CARDIOGENIC SHOCK

More information

Introduction to Acute Mechanical Circulatory Support

Introduction to Acute Mechanical Circulatory Support Introduction to Acute Mechanical Circulatory Support Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive

More information

Bridging With Percutaneous Devices: Tandem Heart and Impella

Bridging With Percutaneous Devices: Tandem Heart and Impella Bridging With Percutaneous Devices: Tandem Heart and Impella DAVID A. BARAN, MD, FACC, FSCAI SYSTEM DIRECTOR, ADVANCED HEART FAILURE, TX AND MCS SENTARA HEART HOSPITAL NORFOLK, VA PROFESSOR OF MEDICINE

More information

CLARIVEIN INFUSION CATHETER

CLARIVEIN INFUSION CATHETER CLARIVEIN INFUSION CATHETER General Product Description Overview The ClariVein Infusion Catheter (ClariVein -IC) is an infusion catheter system designed to introduce physician-specified medicaments into

More information

Impella Ins & Outs. CarVasz November :45 12:15

Impella Ins & Outs. CarVasz November :45 12:15 Impella Ins & Outs CarVasz November 21 2014 10:45 12:15 Nicolas M. Van Mieghem, MD, PhD, FESC Clinical Director of Interventional Cardiology Thoraxcenter, Erasmus MC Rotterdam Background IABP is widely

More information

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan

ECMO as a bridge to durable LVAD therapy. Jonathan Haft, MD Department of Cardiac Surgery University of Michigan ECMO as a bridge to durable LVAD therapy Jonathan Haft, MD Department of Cardiac Surgery University of Michigan Systolic Heart Failure Prevalence 4.8 million U.S. 287,000 deaths per year $39 billion spent

More information

Case - Advanced HF and Shock (INTERMACS 1)

Case - Advanced HF and Shock (INTERMACS 1) Case - Advanced HF and Shock (INTERMACS 1) Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive Director,

More information

Instructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter

Instructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter Instructions for Use Reprocessed LASSO Circular Mapping Diagnostic Electrophysiology (EP) Catheter Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. DEVICE DESCRIPTION

More information

Section 6 Intra Aortic Balloon Pump

Section 6 Intra Aortic Balloon Pump Section 6 Intra Aortic Balloon Pump The Intra Aortic Balloon Pump (IABP) The balloon is synthetic and is made for single use only. It is threaded into the aorta, usually via a femoral approach. The balloon

More information

Hemodynamic Monitoring and Circulatory Assist Devices

Hemodynamic Monitoring and Circulatory Assist Devices Hemodynamic Monitoring and Circulatory Assist Devices Speaker: Jana Ogden Learning Unit 2: Hemodynamic Monitoring and Circulatory Assist Devices Hemodynamic monitoring refers to the measurement of pressure,

More information

Mechanics of Cath Lab Support Devices

Mechanics of Cath Lab Support Devices Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Chief Medical Officer First Coast Cardiovascular Institute, Jacksonville, FL Professor of Medicine, UCF, Orlando, FL None DISCLOSURE Percutaneous

More information

NON-COMPLIANT PTCA RAPID EXCHANGE DILATATION CATHETER

NON-COMPLIANT PTCA RAPID EXCHANGE DILATATION CATHETER Page 1 of 5 NON-COMPLIANT PTCA RAPID EXCHANGE DILATATION CATHETER STERILE. SINGLE USE ONLY. Sterilized with ethylene oxide gas. Non pyrogenic. Do not resterilize. Do not use opened or damaged packages.

More information

STATE OF OKLAHOMA 2014 EMERGENCY MEDICAL SERVICES PROTOCOLS

STATE OF OKLAHOMA 2014 EMERGENCY MEDICAL SERVICES PROTOCOLS 5M VENTRICULAR ASSIST DEVICE (VAD) MANAGEMENT ADULT EMERGENCY MEDICAL DISPATCHER EMERGENCY MEDICAL RESPONDER EMT EMT-INTERMEDIATE 85 ADVANCED EMT PARAMEDIC A Ventricular Assist Device, or VAD, is a mechanical

More information

Relax and Learn At the Farm 2012

Relax and Learn At the Farm 2012 Relax and Learn At the Farm Session 9: Invasive Hemodynamic Assessment and What to Do with the Data Carol Jacobson RN, MN Cardiovascular Nursing Education Associates Function of CV system is to deliver

More information

RECOMMENDED INSTRUCTIONS FOR USE

RECOMMENDED INSTRUCTIONS FOR USE Rapid Exchange PTCA Dilatation Catheter RECOMMENDED INSTRUCTIONS FOR USE Available in diameters 1.25mm to 4.5mm and in lengths 09mm to 40mm Caution: This device should be used only by physicians trained

More information

Rhondalyn C. McLean. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VII, A. Study Purpose and Rationale

Rhondalyn C. McLean. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VII, A. Study Purpose and Rationale A Randomized Clinical Study To Compare The Intra-Aortic Balloon Pump To A Percutaneous Left Atrial-To-Femoral Arterial Bypass Device For Treatment Of Cardiogenic Shock Following Acute Myocardial Infarction.

More information

Assist Devices in STEMI- Intra-aortic Balloon Pump

Assist Devices in STEMI- Intra-aortic Balloon Pump Assist Devices in STEMI- Intra-aortic Balloon Pump Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center Athens, Greece Cardiogenic shock 5-10% of pts after a heart attack 60000-70000 pts in Europe/year

More information

Mechanics of Cath Lab Support Devices

Mechanics of Cath Lab Support Devices Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida DISCLOSURE Presenter:

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Document No. BMB/IFU/40 Rev No. & Date 00 & 15/11/2017 Issue No & Date 01 & 15/11/2017

Document No. BMB/IFU/40 Rev No. & Date 00 & 15/11/2017 Issue No & Date 01 & 15/11/2017 Central Venous Catheter Device Description Multi-lumen catheters incorporate separate, non-communicating vascular access lumens within a single catheter body. Minipunctur Access Sets And Trays: Used for

More information

AllinaHealthSystem 1

AllinaHealthSystem 1 : Definition End-organ hypoperfusion secondary to cardiac failure Venoarterial ECMO: Patient Selection Michael A. Samara, MD FACC Advanced Heart Failure, Cardiac Transplant & Mechanical Circulatory Support

More information

Cardiogenic Shock in Acute MI

Cardiogenic Shock in Acute MI Cardiogenic Shock in Acute MI Mark Sheldon, MD UNMH Interventional Cardiology Objectives Overview Treatment Definition Shock profiles Causes Medical Mechanical Illustrative case Questions? Revascularization

More information

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes 8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference 2017 OSPEDALE Dubai: 19-21 October 2017 Acute Coronary Syndromes Antonio Colombo Centro Cuore Columbus and S. Raffaele

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Cardiogenic Shock Mechanical Support Eulàlia Roig FESC Heart Failure and HT Unit Hospital Sant Pau - UAB Barcelona. Spain No conflics of interest Mechanical Circulatory

More information

Ventricular Assisting Devices in the Cathlab. Unrestricted

Ventricular Assisting Devices in the Cathlab. Unrestricted Ventricular Assisting Devices in the Cathlab Unrestricted What is a VAD? A single system device that is surgically attached to the left ventricle of the heart and to the aorta for left ventricular support

More information

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Peel-Apart Percutaneous Introducer Kits for

Peel-Apart Percutaneous Introducer Kits for Bard Access Systems Peel-Apart Percutaneous Introducer Kits for Table of Contents Contents Page Bard Implanted Ports Hickman*, Leonard*, Broviac*, Tenckhoff*, and Groshong* Catheters Introduction....................................

More information

MCS for Acute Heart Failure Eric Adler MD Associate Professor of Medicine Medical Director Cardiac Transplant

MCS for Acute Heart Failure Eric Adler MD Associate Professor of Medicine Medical Director Cardiac Transplant MCS for Acute Heart Failure 2016 Eric Adler MD Associate Professor of Medicine Medical Director Cardiac Transplant Why do we decompensate? Which Heart Failure Patients Should Get Palliative Care and Who

More information

Heart transplantation is the gold standard treatment for

Heart transplantation is the gold standard treatment for Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but

More information

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research

Mechanical Cardiac Support in Acute Heart Failure. Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Mechanical Cardiac Support in Acute Heart Failure Michael Felker, MD, MHS Associate Professor of Medicine Director of Heart Failure Research Disclosures Research Support and/or Consulting NHLBI Amgen Cytokinetics

More information

Nit-Occlud. Coil System for PDA Closure IMPLANTATION POCKET GUIDE. Rx only CV / B. Braun Interventional Systems Inc.

Nit-Occlud. Coil System for PDA Closure IMPLANTATION POCKET GUIDE. Rx only CV / B. Braun Interventional Systems Inc. Refer to the Nit-Occlud PDA Instructions for Use for relevant warnings, precautions, complications and contraindications. This device has been designed for single use only. Nit-Occlud Coil System for PDA

More information

Circulatory Support: From IABP to LVAD

Circulatory Support: From IABP to LVAD Circulatory Support: From IABP to LVAD Howard A Cohen, MD, FACC, FSCAI Director Division of Cardiovascular Intervention Co Director Cardiovascular Interventional ti Laboratories Lenox Hill Heart & Vascular

More information

ER REBOA Catheter. Instructions for Use

ER REBOA Catheter. Instructions for Use ER REBOA Catheter Instructions for Use Prytime Medical Devices, Inc. 229 N. Main Street Boerne, TX 78006, USA feedback@prytimemedical.com www.prytimemedical.com US 1 210 340 0116 U.S. and Foreign Patents

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Quick Reference Guide

Quick Reference Guide Quick Reference Guide Indications for Use The AFX Endovascular AAA System is indicated for endovascular treatment in patients with AAA. The devices are indicated for patients with suitable aneurysm morphology

More information

ST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do?

ST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do? ST-Elevation Myocardial Infarction & Cardiogenic Shock - What Should We Do? Advanced Angioplasty 2008 Dan Blackman Leeds General Infirmary Conflicts of interest Advisory Boards Cordis Boston Scientific

More information

From Recovery to Transplant: One Patient's Journey

From Recovery to Transplant: One Patient's Journey From Recovery to Transplant: One Patient's Journey Tonya Elliott, RN, MSN Assist Device and Thoracic Transplant Coordinator Inova Transplant Center at Inova Fairfax Hospital Falls Church, VA Introduction

More information

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI Percutaneous Mechanical Circulatory Support for Cardiogenic Shock 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI The Need for Circulatory Support Basic Pathophysiologic Problems:

More information

2018 TCT Investor Update

2018 TCT Investor Update 1 2018 TCT Investor Update September 2018 LEGAL DISCLAIMERS 2 This presentation contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the

More information

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management

Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management Planned, Short-Term RVAD During Durable LVAD Implant: Indications and Management Yoshifumi Naka, MD, PhD Columbia University Medical Center New York, NY Disclosure Abbott/St. Jude Med./Thoratec Consultant

More information

Vascu-PICC WITH CUFF PERIPHERALLY INSERTED CENTRAL VEIN ACCESS CATHETER INSTRUCTIONS FOR USE

Vascu-PICC WITH CUFF PERIPHERALLY INSERTED CENTRAL VEIN ACCESS CATHETER INSTRUCTIONS FOR USE Vascu-PICC WITH CUFF PERIPHERALLY INSERTED CENTRAL VEIN ACCESS CATHETER INSTRUCTIONS FOR USE INDICATIONS FOR USE: The Vascu-PICC with cuff Peripherally Inserted Central Vein Catheters are designed for

More information

i INTERACTIVE CATALOG FIND YOUR IDEAL CANNULAE

i INTERACTIVE CATALOG FIND YOUR IDEAL CANNULAE i INTERACTIVE CATALOG FIND YOUR IDEAL CANNULAE Catalog 2017 i USER TIPS Easily navigate through the pages in our 2017 Cannula Catalog by using the mini-menu shown on upper right of each page. Navigate

More information

I SEE THE BROADEST RANGE OF PRODUCTS THRU my smallest possible incision.*

I SEE THE BROADEST RANGE OF PRODUCTS THRU my smallest possible incision.* I SEE THE BROADEST RANGE OF PRODUCTS THRU my smallest possible incision.* Edwards ThruPort Systems The complete system for minimal incision valve surgery (MIVS) Prep Guide MIVS Redefined > THRUPORT SYSTEMS

More information

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013

Implantable Ventricular Assist Devices and Total Artificial Hearts. Policy Specific Section: June 13, 1997 March 29, 2013 Medical Policy Implantable Ventricular Assist Devices and Total Artificial Hearts Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective

More information

Type Size AP/PS RP/RS Qp/Qs. Ia Resistive <0.3 < Ib Resistive <0.3 < IIa Resistive <0.5 >2

Type Size AP/PS RP/RS Qp/Qs. Ia Resistive <0.3 < Ib Resistive <0.3 < IIa Resistive <0.5 >2 Transcatheter closure of VSD using Duct Occluder device Nguyen Lan Hieu, MD, PhD Hanoi Medical University Vietnam Heart Institute Anatomy of VSD 1. Perimembranous VSD: Aneurysm septal membranous(tv or

More information

Right Ventricular Failure: Prediction, Prevention and Treatment

Right Ventricular Failure: Prediction, Prevention and Treatment Right Ventricular Failure: Prediction, Prevention and Treatment 3 rd European Training Symposium for Heart Failure Cardiologists and Cardiac Surgeons University Hospital Bern June 24-25, 2016 Disclosures:

More information

Directions For Use. All directions should be read before use

Directions For Use. All directions should be read before use Directions For Use All directions should be read before use DEVICE DESCRIPTION: The CLEANER.XT Rotational Thrombectomy System is a percutaneous, 6Fr catheter based system (single piece construction) that

More information

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012

Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart

More information

The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use

The SplitWire Percutaneous Transluminal Angioplasty Scoring Device. Instructions for Use The SplitWire Percutaneous Transluminal Angioplasty Scoring Device Instructions for Use Contents Contains one (1) SplitWire device. Sterile. Sterilized with ethylene oxide gas. Radiopaque. For single use

More information

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella

Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella Outcomes for 15,259 US Patients With Acute MI Cardiogenic Shock (AMICS) Supported With Impella William O Neill, MD, FACC Medical Director Structural Heart Disease at Henry Ford Hospital, MI AMI Shock Mortality

More information

Acute Myocardial Infarction Complicated by Cardiogenic Shock

Acute Myocardial Infarction Complicated by Cardiogenic Shock Acute Myocardial Infarction Complicated by Cardiogenic Shock Navin K. Kapur, MD, FACC, FSCAI Assistant Professor, Division of Cardiology Director, Acute Circulatory Support Program Director, Interventional

More information

High Risk PCI for Heart Failure

High Risk PCI for Heart Failure High Risk PCI for Heart Failure Ray Matthews MD Professor of Clinical Medicine Chief, Division of Cardiovascular Medicine University of Southern California Los Angeles, California Disclosures Abiomed Research

More information

Strengthening Your VAD Program

Strengthening Your VAD Program Disclosure: I have no financial conflicts of interest. Strengthening Your VAD Program Octavio E. Pajaro MD, PhD Chair, Cardiothoracic Surgery Mayo Clinic Arizona Surgical Director, Heart Transplantation

More information

Disclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report

Disclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock Christopher K. Gordon MSN, ACNP-BC Disclosures I have no disclosures to report 1. Pathophysiology 2. Epidemiology 3. Assessment

More information

Advancing Lives and the Delivery of Health Care. The High-Flow Port Designed for Apheresis

Advancing Lives and the Delivery of Health Care. The High-Flow Port Designed for Apheresis Advancing Lives and the Delivery of Health Care The High-Flow Port Designed for Apheresis Optimized for Long Device Life Bench Tested up to 1,000 Accesses 1 Bard is proud to introduce the first and only

More information

CENTRAL ECMO WHEN AND HOW? RANJIT JOHN, MD UNIVERSITY OF MINESOTA

CENTRAL ECMO WHEN AND HOW? RANJIT JOHN, MD UNIVERSITY OF MINESOTA CENTRAL ECMO WHEN AND HOW? RANJIT JOHN, MD UNIVERSITY OF MINESOTA Background How to do Case reports When to do Managing complications Post operative management strategies CASE PRESENTATION 46 year old

More information

Aspira* Peritoneal Drainage Catheter

Aspira* Peritoneal Drainage Catheter Aspira* Peritoneal Drainage Catheter Instructions For Use Access Systems Product Description: The Aspira* Peritoneal Drainage Catheter is a tunneled, long-term catheter used to drain accumulated fluid

More information

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies

Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies Modern Left Ventricular Assist Devices (LVAD) : An Intro, Complications, and Emergencies ERIC T. ROME D.O. HEART FAILURE, MECHANICAL ASSISTANCE AND TRANSPLANTATION CVI Left Ventricular Assist Device An

More information

Complications of Acute Myocardial Infarction

Complications of Acute Myocardial Infarction Acute Myocardial Infarction Complications of Acute Myocardial Infarction Diagnosis and Treatment JMAJ 45(4): 149 154, 2002 Hiroshi NONOGI Director, Division of Cardiology and Emergency Medicine, National

More information

Cath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU

Cath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU Cath Lab Essentials: Basic Hemodynamics for the Cath Lab and ICU Ailin Barseghian El-Farra, MD, FACC Assistant Professor, Interventional Cardiology University of California, Irvine Department of Cardiology

More information

How to do Primary Angioplasty. - Patients with Cardiogenic Shock

How to do Primary Angioplasty. - Patients with Cardiogenic Shock How to do Primary Angioplasty - Patients with Cardiogenic Shock Advanced Cardiovascular Intervention 2011 Dan Blackman Leeds General Infirmary MY CONFLICTS OF INTEREST ARE: Research Grants Medicines Company

More information

ompanionport Speciality Medical Devices For The Veterinary Community Surgical Suggestions

ompanionport Speciality Medical Devices For The Veterinary Community Surgical Suggestions Speciality Medical Devices For The Veterinary Community suture holes Place the CompanionPort in the subcutaneous port pocket off to one side so that the septum of the port will not lie directly beneath

More information

เอกราช อร ยะช ยพาณ ชย

เอกราช อร ยะช ยพาณ ชย 30 July 2016 เอกราช อร ยะช ยพาณ ชย Heart Failure and Transplant Cardiology aekarach.a@chula.ac.th Disclosure Speaker, CME service: Merck, Otsuka, Servier Consultant, non-cme service: Novartis, Menarini

More information

Patient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the

Patient guide: pfm Nit-Occlud PDA coil occlusion system. Catheter occlusion of. Patent Ductus Arteriosus. with the Patient guide: Catheter occlusion of Patent Ductus Arteriosus with the pfm Nit-Occlud PDA coil occlusion system pfm Produkte für die Medizin - AG Wankelstr. 60 D - 50996 Cologne Phone: +49 (0) 2236 96

More information

Andrew Civitello MD, FACC

Andrew Civitello MD, FACC Timing the Transition from Short Term to Long Term Mechanical Circulatory Support Andrew Civitello MD, FACC Medical Director, Heart Transplant Program Director, Fellowship Co-Director, Baylor St. Luke's

More information

I Was Too Late With Device Placement

I Was Too Late With Device Placement SCAI SHOCK 2018 A Team-Based Course On Cardiogenic Shock General Session # 2 Saturday, October 13, 2018 8:39 8:51 AM Boston Park Plaza - Boston, MA I Was Too Late With Device Placement M Chadi Alraies,

More information

ThruPort systems ProPlege peripheral retrograde cardioplegia device

ThruPort systems ProPlege peripheral retrograde cardioplegia device ThruPort systems ProPlege peripheral retrograde cardioplegia device Training Module Lessons Lesson 1: ProPlege device Lesson 2: Preparing for the case Lesson 3: Utilizing the device Lesson 4: Troubleshooting

More information

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017 Parigi: May 16-19, 2017 Miracor Symposium Speaker: 15 Antonio Colombo Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy Nothing to disclose PiCSO Impulse System Elective high risk

More information

Technique. Technique. Technique. Monitoring 1. Local anesthetic? Aseptic technique Hyper-extend (if radial)

Technique. Technique. Technique. Monitoring 1. Local anesthetic? Aseptic technique Hyper-extend (if radial) Critical Care Monitoring Hemodynamic Monitoring Arterial Blood Pressure Cannulate artery Uses 2 Technique Sites Locate artery, prep 3 1 Technique Local anesthetic? Aseptic technique Hyper-extend (if radial)

More information

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know!

Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know! Mechanical Circulatory Support (MCS): What Every Pharmacist Needs to Know! Matthew A. Wanat, PharmD, BCPS, BCCCP, FCCM Clinical Assistant Professor University of Houston College of Pharmacy Clinical Pharmacy

More information

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure

More information

Intra-operative Echocardiography: When to Go Back on Pump

Intra-operative Echocardiography: When to Go Back on Pump Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria

More information

Extracorporeal Membrane Oxygenation (ECMO)

Extracorporeal Membrane Oxygenation (ECMO) Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2017 Section: Other/Miscellaneous

More information

Understanding the Cardiopulmonary Bypass Machine and Its Tubing

Understanding the Cardiopulmonary Bypass Machine and Its Tubing Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of

More information

Extra Corporeal Life Support for Acute Heart failure

Extra Corporeal Life Support for Acute Heart failure Extra Corporeal Life Support for Acute Heart failure Benjamin Medalion, MD Director Heart and Lung Transplantation Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus, Israel Mechanical

More information

Diagnosis of Device Thrombosis

Diagnosis of Device Thrombosis Diagnosis of Device Thrombosis Andrew Civitello MD, FACC Medical Director, Heart Transplant Program Director, Fellowship Co-Director, Baylor St. Luke's Medical Center / Texas Heart Institute Trends in

More information

Cardiogenic Shock. Dr. JPS Henriques. Academic Medical Center University of Amsterdam The Netherlands

Cardiogenic Shock. Dr. JPS Henriques. Academic Medical Center University of Amsterdam The Netherlands Cardiogenic Shock Dr. JPS Henriques Academic Medical Center University of Amsterdam The Netherlands Conflict of interest disclosure Research grant Abbott Vascular Research grant Abiomed Inc. Global Impella

More information

CATCH A WAVE.. INTRODUCTION NONINVASIVE HEMODYNAMIC MONITORING 4/12/2018

CATCH A WAVE.. INTRODUCTION NONINVASIVE HEMODYNAMIC MONITORING 4/12/2018 WAVES CATCH A WAVE.. W I S C O N S I N P A R A M E D I C S E M I N A R A P R I L 2 0 1 8 K E R I W Y D N E R K R A U S E R N, C C R N, E M T - P Have you considered that if you don't make waves, nobody

More information

Echo assessment of patients with an ECMO device

Echo assessment of patients with an ECMO device Echo assessment of patients with an ECMO device Evangelos Leontiadis Cardiologist 1st Cardiology Dept. Onassis Cardiac Surgery Center Athens, Greece Gibbon HLM 1953 Goldstein DJ et al, NEJM 1998; 339:1522

More information

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Associate Professor, Division of Cardiology Director, Acute Circulatory Support Program

More information

UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS

UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS UNIVERSITY OF UTAH HEALTH CARE HOSPITALS AND CLINICS CARDIAC MECHANICAL SUPPORT PROGRAM GUIDELINES CARDIAC MECHANICAL SUPPORT: LVAD BASICS FREQUENT SCENARIOS AND TROUBLESHOOTING Review Date: July 2011

More information

To ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW

To ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW To ECMO Or Not To ECMO Challenges of venous arterial ECMO Dr Emily Granger St Vincent s Hospital Darlinghurst NSW The Start: 1972 St Vincent s Hospital The Turning Point ECMO program restarted in 2004

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support

Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support Matching Patient and Pump in the New Era of Percutaneous Mechanical Circulatory Support Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced

More information